| pKd_min | pKd_max | pIC50_min | pIC50_max | Type | Action | Reference (PubMed ID) |
|---|---|---|---|---|---|---|
| 8.7 | 8.7 | Inhibitor | Inhibition | 21028894 | ||
| Inhibitor | Inhibition | |||||
| 8.1 | 8.1 | Inhibitor | Inhibition | 21028894 | ||
| 7.8 | 7.8 | Inhibitor | Inhibition | 16891463 | ||
| 6.5 | 6.5 | Inhibitor | Inhibition | 12815052 | ||
| 9.4 | 9.4 | 7.9 | 7.9 | Inhibitor | Inhibition | 20570526,22037378 |
| 6.8 | 6.8 | Inhibitor | Inhibition | 12124172 | ||
| 7.7 | 7.7 | Inhibitor | Inhibition | 26233509 | ||
| 6.4 | 7.6 | Inhibitor | Inhibition | 16424037 | ||
| 8 | 8 | Inhibitor | Inhibition | |||
| 8 | 8 | Inhibitor | Inhibition | 22765894 | ||
| 5.4 | 5.4 | Inhibitor | Inhibition | 24498562 | ||
| 8 | 8 | Inhibitor | Inhibition | 18077363 | ||
| 7.5 | 7.5 | Inhibitor | Inhibition | 22864397 | ||
| 7.5 | 7.5 | Inhibitor | Inhibition | 27545040 | ||
| 9 | 9 | Inhibitor | Inhibition | 24900421 | ||
| 8.3 | 8.3 | Inhibitor | Inhibition | 23521020 | ||
| 6.3 | 6.3 | Inhibitor | Inhibition | 22304225 | ||
| 7.7 | 7.7 | Inhibitor | Inhibition | 22935731 | ||
| 6.4 | 6.4 | Inhibitor | Inhibition | 21443688 |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0002299000 uM | Activity at 0.0009353959 uM | Activity at 0.00184 uM | Activity at 0.00468 uM | Activity at 0.00919 uM | Activity at 0.016 uM | Activity at 0.027 uM | Activity at 0.051 uM | Activity at 0.092 uM | Activity at 0.155 uM | Activity at 0.256 uM | Activity at 0.462 uM | Activity at 0.846 uM | Activity at 1.283 uM | Activity at 2.310 uM | Activity at 4.246 uM | Activity at 6.551 uM | Activity at 11.58 uM | Activity at 25.26 uM | Activity at 38.52 uM | Activity at 57.54 uM | Activity at 116.1 uM | Activity at 221.6 uM | Activity at 288.3 uM | Panel ID | Panel Name |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0.0891 | 20.4377 | 0 | -7.05 | 4.9549 | 0.5243 | 16 | -4.4377 | 4 | 0 0 0 0 0 | 13.1195 | -1.6147 | 23.0221 | 4.9232 | 22.4364 | 13.1195 | 3 | PA-1 | |||||||||||||||||||||
| Inactive | 0.5012 | 19.512 | 0 | -6.3 | 4.5045 | 0.9837 | 2.5 | -17.012 | 4 | 0 0 0 0 0 | 4.6148 | -17.0933 | -15.139 | 2.0203 | 0.9631 | 4.6148 | 4 | SKOV3 | |||||||||||||||||||||
| Inactive | 0.0891 | 10.1784 | 0 | -7.05 | 4.9549 | 0.4664 | -7.6784 | 2.5 | 4 | 0 0 0 0 0 | -7.2247 | 0.9983 | -11.3986 | -10.48 | -0.961 | -7.2247 | 5 | C33A | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 6.8018 | -1.7943 | 7.9288 | 7.7169 | 7.1557 | 6.8018 | 6 | JEG-3 | ||||||||||||||||||||||||||
| Inactive | 0.631 | 5.8754 | 0 | -6.2 | 4.9549 | 0.6533 | 5 | -0.8754 | 4 | 0 0 0 0 0 | 4.9978 | 0.7404 | -1.9795 | 8.0951 | 2.3607 | 4.9978 | 7 | Es-2 | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -1.5659 | 2.9339 | -4.8958 | -4.7951 | 1.5969 | -1.5659 | 8 | Hek293T | ||||||||||||||||||||||||||
| Inactive | 0.0891 | 9.995 | 0 | -7.05 | 4.9549 | 0.3786 | -7.495 | 2.5 | 4 | 0 0 0 0 0 | -5.4128 | 1.1477 | -11.5205 | -0.3743 | -12.9125 | -5.4128 | 9 | Tov112D | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -3.2957 | 3.8308 | 1.4062 | -4.436 | -2.7163 | -3.2957 | 10 | Tov-21-G | ||||||||||||||||||||||||||
| Inactive | 0.7079 | 14.6604 | 0 | -6.15 | 4.9549 | 0.9994 | 11.5 | -3.1604 | 4 | 0 0 0 0 1 | 1.8313 | -3.0503 | -3.0355 | 11.1111 | 11.2024 | 1.8313 | 11 | OV90 | |||||||||||||||||||||
| Inactive | 2.5119 | 11.0392 | 0 | -5.6 | 1.6259 | 0.9918 | 4.5 | -6.5392 | 4 | 0 0 0 0 0 | 4.3244 | -5.7563 | -6.6993 | -3.0441 | 3.0217 | 4.3244 | 12 | CASKI | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 4.0002 | 9.2609 | 1.7307 | 16.1689 | 8.2706 | 4.0002 | 1 | CAOV3 | ||||||||||||||||||||||||||
| Inactive | 0.1 | 12.4224 | 0 | -7 | 1.6436 | 0.8881 | -1.9224 | 10.5 | 4 | 0 0 0 0 0 | -4.5186 | 7.7607 | 0.4819 | -0.6217 | -0.7957 | -4.5186 | 2 | HeLa | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 9.027 | 13.2513 | 1.7412 | 13.5275 | 17.6857 | 9.027 | 3 | PA-1 | ||||||||||||||||||||||||||
| Inactive | 0.3162 | 18 | 0 | -6.5 | 4.4495 | 0.9637 | 7 | 25 | 4 | 0 0 0 0 1 | 19.6871 | 25.2034 | 21.5131 | 5.0173 | 9.4271 | 19.6871 | 4 | SKOV3 | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0.3369 | 0.4452 | -0.9125 | 5.7292 | 4.44 | 0.3369 | 5 | C33A | ||||||||||||||||||||||||||
| Inactive | 0.0631 | 10.5 | 0 | -7.2 | 4.9549 | 0.8451 | 2 | 12.5 | 4 | 0 0 0 0 0 | 1.0879 | 10.8386 | 0.1902 | 2.4619 | 4.6395 | 1.0879 | 6 | JEG-3 | |||||||||||||||||||||
| Inactive | 0.5012 | 9.5598 | 0 | -6.3 | 4.9549 | 0.9517 | 0 | -9.5598 | 4 | 0 0 0 0 0 | -0.0179 | -8.4158 | -10.4665 | 0.9667 | -1.2439 | -0.0179 | 7 | Es-2 | |||||||||||||||||||||
| Inactive | 0.0631 | 14.8119 | 0 | -7.2 | 4.9549 | 0.534 | -5.8119 | 9 | 4 | 0 0 0 0 1 | 0.2814 | 6.5861 | -12.7599 | 1.4268 | -6.0897 | 0.2814 | 8 | Hek293T | |||||||||||||||||||||
| Inactive | 8.9125 | 8.541 | 0 | -5.05 | 4.045 | 0.614 | 8 | -0.541 | 4 | 0 0 0 0 0 | 7.7519 | 3.7595 | -4.2009 | -0.5734 | 0.6635 | 7.7519 | 9 | Tov112D | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 1.0625 | -0.4666 | 0.2533 | -1.2691 | -7.1333 | 1.0625 | 10 | Tov-21-G |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.042 | Kd | = | 42 | nM |
| 2.1 | Kd | = | 2100 | nM |
| 2.5 | Kd | = | 2500 | nM |
| 0.84 | Kd | = | 840 | nM |
| 0.17 | Kd | = | 170 | nM |
| 2.6 | Kd | = | 2600 | nM |
| 6.3 | Kd | = | 6300 | nM |
| 1.7 | Kd | = | 1700 | nM |
| 0.56 | Kd | = | 560 | nM |
| 0.067 | Kd | = | 67 | nM |
| 0.33 | Kd | = | 330 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000073560 uM | Activity at 0.0000367800 uM | Activity at 0.0000735600 uM | Activity at 0.0001677464 uM | Activity at 0.0003678000 uM | Activity at 0.0007363003 uM | Activity at 0.00153 uM | Activity at 0.00368 uM | Activity at 0.00723 uM | Activity at 0.00914 uM | Activity at 0.018 uM | Activity at 0.039 uM | Activity at 0.092 uM | Activity at 0.191 uM | Activity at 0.460 uM | Activity at 0.910 uM | Activity at 1.182 uM | Activity at 2.302 uM | Activity at 4.834 uM | Activity at 11.49 uM | Activity at 23.94 uM | Activity at 57.45 uM | Activity at 115.4 uM | Activity at 193.5 uM | Activity at 288.3 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.0964 | 121.5245 | 87 | Complete curve; high efficacy | -5.96 | 0.6 | 0.996 | -99.001 | 22.5235 | -1.1 | 0 0 0 0 0 0 0 0 | -91.4164 | 21.201 | 18.0897 | 11.5563 | 3.2362 | -23.6097 | -54.3722 | -70.1237 | -91.4164 | QC'd by GVK | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3029 | 6.409 | 5.7452 | -8.1274 | 11.4345 | 12.799 | 5.9113 | 7.1389 | 1.3029 | QC'd by Vitas | |||||||||||||||||||||||||
| Inhibitor | 0.055 | 96.7494 | 90 | Complete curve; high efficacy | -7.26 | 0.6 | 0.9836 | -74.1574 | 22.592 | -1.1 | 0 0 0 0 0 0 0 0 | -78.8495 | 12.3459 | 12.9899 | -11.4013 | -37.5586 | -53.042 | -61.5426 | -65.313 | -78.8495 | QC'd by Bosche | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -9.339 | -4.094 | -2.8674 | 4.5071 | -4.4459 | -5.3433 | -2.4671 | 3.5091 | -9.339 | QC'd by BIOMOL | |||||||||||||||||||||||||
| Inactive | 0 | -6.61 | 4.9549 | 0.7785 | 2.5 | -6.0941 | 4 | 0 0 0 0 0 0 0 1 | -8.7946 | -5.07 | -2.6335 | -5.97 | -10.4951 | 3.4911 | 2.0588 | 1.9174 | -8.7946 | QC'd by SIGMA | |||||||||||||||||||||
| Inhibitor | 34.6713 | 39.827 | 10 | Single point of activity | -4.46 | 2.3031 | 0.825 | -41.327 | -1.5 | -3 | 0 0 0 0 0 0 0 0 | -31.9392 | 3.6009 | -5.2617 | 2.2295 | 4.1407 | -8.6455 | -6.9529 | -4.2362 | -31.9392 | QC'd by Microsource | ||||||||||||||||||
| Inactive | 0 | 4 | 0 0 0 0 0 0 0 0 | -13.8986 | 20.6492 | 16.422 | 11.6893 | 9.5011 | 16.6467 | -2.6177 | -2.1673 | -13.8986 | QC'd by Vitas | ||||||||||||||||||||||||||
| Inhibitor | 15.4871 | 78.5667 | 41 | Partial curve; partial efficacy | -4.81 | 0.8 | 0.995 | -76.672 | 1.8947 | -2.2 | 0 0 0 0 0 0 0 0 | -58.0849 | 2.7342 | 0.6745 | 4.0214 | -0.609 | -3.975 | -12.9528 | -31.6593 | -58.0849 | QC'd by Sequoia | ||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 26.6445 | 12.4429 | -0.6442 | 19.3784 | 7.3352 | 0.3513 | 4.2285 | 7.4344 | 26.6445 | QC'd by Microsource | |||||||||||||||||||||||||
| Inactive | 0 | -5.9213 | 4.9549 | 0.7942 | 3.5 | -5.6452 | 4 | 0 0 0 0 0 0 1 | -9.4213 | -2.1113 | -8.4544 | -4.6822 | -8.2265 | 4.1606 | 2.7472 | -9.4213 | QC'd by Tocris | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.8012 | -11.1342 | -2.192 | 0 | -10.8176 | -0.6934 | -3.3166 | -1.4979 | -2.8012 | QC'd by SIGMA | |||||||||||||||||||||||||
| Inactive | 0 | -5.76 | 4.9549 | 0.5104 | 28.8996 | -2.448 | 4 | 0 1 0 0 0 0 0 1 | -2.305 | 23.7377 | -36.8683 | -4.4543 | -19.5675 | -9.3801 | 22.2432 | 29.0984 | -2.305 | QC'd by Vitas | |||||||||||||||||||||
| Inhibitor | 12.3018 | 87.4011 | 42 | Partial curve; high efficacy | -4.91 | 0.6 | 0.9549 | -73.5501 | 13.8509 | -2.1 | 0 0 0 0 0 0 0 0 | -54.8735 | 22.1453 | 8.3684 | 12.1328 | 9.0141 | -1.3852 | -8.6537 | -22.9862 | -54.8735 | QC'd by Microsource | ||||||||||||||||||
| Inhibitor | 27.5404 | 50.2393 | 10 | Single point of activity | -4.56 | 1.7529 | 0.9401 | -50.1648 | 0.0744 | -3 | 0 0 0 0 0 0 0 0 | -39.14 | 2.8036 | -3.0335 | 1.3596 | -6.0162 | 5.1159 | -1.7887 | -9.2175 | -39.14 | QC'd by Microsource | ||||||||||||||||||
| Inactive | 0 | -5.31 | 0.6 | 0.8041 | -16.0136 | 17 | 4 | 0 0 0 0 0 0 0 0 | -11.678 | 17.6825 | 13.4358 | 21.7597 | 6.5197 | 17.4375 | -0.6278 | -0.9036 | -11.678 | QC'd by Enzo | |||||||||||||||||||||
| Inhibitor | 15.4871 | 77.5471 | 10 | Partial curve; partial efficacy; poor fit | -4.81 | 1.111 | 0.829 | -67.106 | 10.4411 | -2.4 | 0 0 0 0 0 0 0 0 | -53.0541 | 0.7435 | 24.1655 | 2.7053 | 1.7382 | 25.7669 | -4.8999 | -19.2859 | -53.0541 | QC'd by Bosche | ||||||||||||||||||
| Inactive | 0 | -6.36 | 1.4641 | 0.8922 | -22.4758 | 4.5 | 4 | 0 0 0 0 0 0 0 0 | -25.4997 | 2.5425 | 6.3039 | 7.767 | -1.9911 | -6.3102 | -26.2299 | -15.2464 | -25.4997 | QC'd by Microsource | |||||||||||||||||||||
| Inactive | 0 | -4.51 | 1.9673 | 0.499 | 14 | 26.5 | 4 | 0 0 0 0 0 0 0 0 | 16.8462 | 25.5317 | 32.6702 | 20.2852 | 28.5693 | 25.6359 | 26.9817 | 25.0297 | 16.8462 | QC'd by GVK | |||||||||||||||||||||
| Inhibitor | 0.8709 | 47.2788 | 24 | Complete curve; partial efficacy | -6.06 | 4.9549 | 0.9676 | -45.6766 | 1.6021 | -1.2 | 0 0 0 0 0 0 0 1 | -20.5127 | 8.2743 | 0.9756 | -1.5573 | -1.3097 | 0.8922 | -49.683 | -41.1152 | -20.5127 | QC'd by Enzo | ||||||||||||||||||
| Inactive | 0 | -6.06 | 4.9549 | 0.439 | 9 | -0.6762 | 4 | 0 0 0 0 0 0 0 1 | -0.013 | 1.9538 | 1.5464 | -4.3135 | 0.312 | -2.7682 | 16.9354 | 0.8252 | -0.013 | QC'd by Sequoia |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000040000 uM | Activity at 0.0000163452 uM | Activity at 0.0000320000 uM | Activity at 0.0000806082 uM | Activity at 0.0001439601 uM | Activity at 0.0003895389 uM | Activity at 0.0007288991 uM | Activity at 0.00154 uM | Activity at 0.00290 uM | Activity at 0.00454 uM | Activity at 0.00833 uM | Activity at 0.021 uM | Activity at 0.041 uM | Activity at 0.095 uM | Activity at 0.199 uM | Activity at 0.321 uM | Activity at 0.689 uM | Activity at 1.028 uM | Activity at 2.684 uM | Activity at 5.101 uM | Activity at 10.05 uM | Activity at 24.85 uM | Activity at 39.21 uM | Activity at 78.39 uM | Activity at 125.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 58.4116 | 43.5916 | 25.8843 | 33.4207 | 9.1109 | 21.6395 | 45.6886 | 10.8911 | 28.3955 | 31.3127 | 38.9914 | 41.6558 | 58.4116 | QC'd by Sytravon | |||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -12.6805 | -10.7548 | -9.5107 | -10.6418 | -15.9997 | -12.6805 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -7.1462 | -9.2235 | -11.8601 | -6.118 | -12.2196 | -7.1462 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.6661 | -22.0013 | -2 | 4 | 0 0 0 0 0 | -18.751 | -10.987 | -0.9935 | 2.356 | 1.2583 | -18.751 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -11.1249 | -10.2692 | -11.5229 | -11.032 | -13.325 | -11.1249 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.8 | 1.8851 | 0.5555 | -23.9168 | -5.4088 | 4 | 0 0 0 0 0 | -18.264 | -13.0121 | -2.8407 | -6.6548 | -7.1687 | -18.264 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.35 | 4.9549 | 0.9083 | -3.1815 | -14.9283 | 4 | 0 0 0 0 1 | -10.2909 | -13.1276 | -17.0236 | -1.4012 | -4.6174 | -10.2909 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.95 | 0.4 | 0.9812 | -20.7272 | -0.9942 | 4 | 0 0 0 0 0 | -16.0227 | -4.9952 | -8.1266 | -9.7286 | -14.3153 | -16.0227 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -6.5 | 4.9549 | 0.6409 | -9.2158 | -16.6011 | 4 | 0 0 0 0 1 | -12.7654 | -16.3342 | -16.1896 | -6.0131 | -13.084 | -12.7654 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.975 | 2.6103 | 3.4198 | -3.4748 | 1.7624 | 1.975 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.2223 | -0.1456 | -4.3339 | -1.582 | -3.6253 | -8.2223 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -7.25 | 4.9549 | 0.602 | -10.0715 | 2 | 4 | 0 0 0 0 0 | -12.6011 | 0.2325 | -14.2262 | -4.5441 | -8.7364 | -12.6011 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.5045 | 0.9809 | -24.6554 | -10.8442 | 4 | 0 0 0 0 0 | -22.2129 | -9.8702 | -10.3098 | -11.7375 | -10.6121 | -22.2129 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.8409 | -13.5514 | 2 | 4 | 0 0 0 0 0 | -11.2928 | -1.9276 | 4.6106 | 1.3336 | 4.0275 | -11.2928 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -5.2 | 0.5 | 0.9077 | -28.8252 | -9.4452 | 4 | 0 0 0 0 0 | -23.1876 | -10.7877 | -12.0613 | -16.7104 | -16.3414 | -23.1876 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -18.3436 | -16.2788 | -21.7212 | -19.8613 | -16.6894 | -18.3436 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4025 | -9.518 | -0.1694 | 0.2848 | -4.8162 | -5.4025 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -23.1229 | -14.0834 | -13.5556 | -16.7644 | -18.8145 | -23.1229 | QC'd by Sytravon | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.95 | 3.2975 | 0.9426 | -35.5663 | -15.2262 | 4 | 0 0 0 0 0 | -34.2687 | -12.6885 | -18.3414 | -14.0693 | -16.4909 | -34.2687 | QC'd by Sytravon | ||||||||||||||||||||||||
| Inactive | 0 | -4.75 | 4.9549 | 0.7952 | -15.6253 | -4.8932 | 4 | 0 0 0 0 0 | -13.8544 | -4.3645 | -8.5252 | -3.661 | -3.9903 | -13.8544 | QC'd by Sytravon |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.36 | IC50 | = | 360 | nM |
| 80 | IC50 | > | 80000 | nM |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Growth Rate | = | -0.32 |
| Growth Rate | = | -0.85 |
| Growth Rate | = | 0.66 |
| Growth Rate | = | 0.58 |
| Growth Rate | = | 0.86 |
| Growth Rate | = | 0.06 |
| Growth Rate | = | 0.1 |
| Growth Rate | = | 0.63 |
| Growth Rate | = | 0.67 |
| Growth Rate | = | 0.46 |
| Growth Rate | = | 0.87 |
| Growth Rate | = | 0 |
| Growth Rate | = | 0.46 |
| Growth Rate | = | 0.87 |
| Growth Rate | = | -0.42 |
| Growth Rate | = | -0.57 |
| Growth Rate | = | -0.81 |
| Growth Rate | = | 0.2 |
| Growth Rate | = | 0.77 |
| Growth Rate | = | 0.4 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Growth Rate | = | 0.66 |
| Growth Rate | = | 0.47 |
| Growth Rate | = | 0.81 |
| Growth Rate | = | 0.62 |
| Growth Rate | = | 0.92 |
| Growth Rate | = | 0.99 |
| Growth Rate | = | -0.15 |
| Growth Rate | = | -0.01 |
| Growth Rate | = | 0.69 |
| Growth Rate | = | 0.27 |
| Growth Rate | = | 0.71 |
| Growth Rate | = | 0.38 |
| Growth Rate | = | 0.78 |
| Growth Rate | = | 0.46 |
| Growth Rate | = | 0.9 |
| Growth Rate | = | 0.97 |
| Growth Rate | = | 0.97 |
| Growth Rate | = | 0.5 |
| Growth Rate | = | 0.33 |
| Growth Rate | = | 0.54 |
| Standard Type | Standard Relation | Standard Value |
|---|---|---|
| Growth Rate | = | 0.94 |
| Growth Rate | = | 0.96 |
| Growth Rate | = | 0.56 |
| Growth Rate | = | 0.78 |
| Growth Rate | = | 0.8 |
| Growth Rate | = | 0.92 |
| Growth Rate | = | 0.78 |
| Growth Rate | = | -0.28 |
| Growth Rate | = | -0.1 |
| Growth Rate | = | 0.54 |
| Growth Rate | = | 0.58 |
| Growth Rate | = | 0.72 |
| Growth Rate | = | 0.97 |
| Growth Rate | = | 0.76 |
| Growth Rate | = | 0.97 |
| Growth Rate | = | 0.82 |
| Growth Rate | = | 0.75 |
| Growth Rate | = | 0.87 |
| Growth Rate | = | 0.77 |
| Growth Rate | = | 0.78 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.47 | Kd | = | 470 | nM |
| 0.15 | Kd | = | 150 | nM |
| 0.52 | Kd | = | 520 | nM |
| 0.38 | Kd | = | 380 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.1 | Kd | < | 100 | nM |
| 3.4 | Kd | = | 3400 | nM |
| 3.1 | Kd | = | 3100 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.35 | IC50 | = | 350 | nM |
| 5.98 | IC50 | = | 5980 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | IC50 | > | 10000 | nM |
| 0.38 | IC50 | = | 380 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000059000 uM | Activity at 0.0000296505 uM | Activity at 0.0000627629 uM | Activity at 0.0001361338 uM | Activity at 0.0003144137 uM | Activity at 0.0006678285 uM | Activity at 0.00124 uM | Activity at 0.00266 uM | Activity at 0.00558 uM | Activity at 0.00707 uM | Activity at 0.017 uM | Activity at 0.031 uM | Activity at 0.069 uM | Activity at 0.181 uM | Activity at 0.368 uM | Activity at 0.597 uM | Activity at 1.656 uM | Activity at 1.863 uM | Activity at 4.836 uM | Activity at 9.224 uM | Activity at 16.10 uM | Activity at 45.96 uM | Activity at 92.69 uM | Activity at 155.1 uM | Activity at 231.0 uM | Activity at 0.0000060205 uM | Activity at 0.0000300955 uM | Activity at 0.0000624651 uM | Activity at 0.0001389779 uM | Activity at 0.0003184034 uM | Activity at 0.0006683289 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00492 uM | Activity at 0.00762 uM | Activity at 0.016 uM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 37.2212 | 127.5753 | 10 | Single point of activity | -4.4292 | 4.9549 | 0.9931 | -128.5776 | -1.0023 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -97.4073 | 0 | -4.3324 | 0 | 0 | |||||||||||||||||||||||||||||||||
| Inactive | 0.0132 | 9.4233 | 0 | -7.8792 | 0.7 | 0.5013 | 0.5767 | 10 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 1.9358 | 7.1453 | 12.2414 | 3.0292 | 3.3929 | 7.2562 | 0.5823 | -2.8527 | 5.4621 | -1.3525 | -0.5492 | 1.9358 | |||||||||||||||||||||||||||
| Inactive | 0.059 | 33.854 | 0 | -7.2292 | 0.4 | 0.628 | 32.5 | -1.354 | 4 | 0 0 0 0 0 0 0 0 1 0 1 | 7.5768 | 0.8245 | 9.7 | 16.2951 | -2.795 | 21.7782 | 23.8107 | 18.6186 | 26.701 | -8.7237 | 28.9931 | 7.5768 | |||||||||||||||||||||||||||
| Inhibitor | 37.2212 | 43.1467 | 10 | Single point of activity | -4.4292 | 4.9549 | 0.9703 | -43.1467 | 0 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -32.6223 | 0 | 0 | 0 | 0 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -2.3224 | 6.8981 | -3.1114 | 13.0804 | 9.0389 | 1.997 | 4.8517 | -1.5173 | 8.1374 | 6.737 | 13.5409 | -2.3224 | ||||||||||||||||||||||||||||||||
| Inhibitor | 37.2212 | 95.8343 | 10 | Single point of activity | -4.4292 | 4.9549 | 0.9646 | -96.6556 | -0.8213 | -3 | 0 0 0 0 0 0 0 0 0 0 0 | -73.224 | 0 | 2.0597 | -7.5145 | -4.9351 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | -5.9246 | 13.9115 | -2.2399 | 22.3817 | -3.6902 | 17.6466 | 0.983 | -10.4049 | 6.3941 | 9.0991 | -4.1342 | -5.9246 | ||||||||||||||||||||||||||||||||
| Inhibitor | 26.3506 | 82.767 | 40 | Partial curve; partial efficacy | -4.5792 | 4.095 | 0.8717 | -86.5714 | -3.8044 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -78.842 | -5.938 | 0 | 1.3974 | -28.1211 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0.0224 | 10.2488 | 10.425 | -3.0631 | 6.0889 | 11.7517 | 1.7759 | 1.2299 | 3.863 | 0.5748 | 2.441 | 0.0224 | ||||||||||||||||||||||||||||||||
| Inactive | 3.3173 | 7.8833 | 0 | -5.4792 | 4.9549 | 0.5098 | -2.8833 | 5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -5.7361 | 3.9315 | 5.013 | 6.2883 | -1.9013 | 11.2026 | 6.1203 | 3.2958 | 5.5784 | -2.0286 | 0.5573 | -5.7361 | |||||||||||||||||||||||||||
| Inactive | 37.2212 | 15.8797 | 0 | -4.4292 | 4.9549 | 0.5221 | -17.3797 | -1.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -13.2331 | -1.0197 | -4.2326 | 1.5878 | -1.3704 | ||||||||||||||||||||||||||||||||||
| Inactive | 0.0662 | 7.9339 | 0 | -7.1792 | 0.9 | 0.5932 | 0.5661 | 8.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 1.5667 | 4.5125 | 10.9653 | 11.7719 | 2.2417 | 5.4534 | 2.3108 | 4.412 | -1.6116 | -0.4624 | 0.6218 | 1.5667 | |||||||||||||||||||||||||||
| Inactive | 0.1321 | 25.7701 | 0 | -6.8792 | 4.9549 | 0.559 | -15.7009 | 10.0692 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -20.7968 | -1.3843 | 2.3985 | 2.1327 | 23.5113 | 24.9349 | -16.0908 | 2.2208 | -21.3286 | -30.7571 | -5.6999 | -20.7968 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0 | -2.3996 | -4.4114 | -2.0746 | -4.8678 | |||||||||||||||||||||||||||||||||||||||
| Inactive | 0.6619 | 4.5831 | 0 | -6.1792 | 2.7202 | 0.3338 | -1.0831 | 3.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 4.5686 | 1.8671 | -0.8538 | 4.0573 | 0.4645 | 9.5801 | 4.5394 | 1.4181 | -0.6516 | -1.3193 | -0.6764 | 4.5686 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0 | -0.8005 | 0 | 0.1327 | 0.7944 | |||||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 14.2547 | 2.541 | 1.436 | -2.1356 | 5.2198 | 13.9423 | 15.8165 | 0.9766 | 4.8506 | 2.1093 | -0.6976 | 14.2547 | ||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0 | -49.4569 | -14.2442 | 0 | -2.3916 | |||||||||||||||||||||||||||||||||||||||
| Inactive | 0.8333 | 21.0584 | 0 | -6.0792 | 1.3723 | 0.9479 | -17.0584 | 4 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -3.3027 | 5.8923 | 2.636 | 1.3229 | 7.0584 | 3.9452 | 0.8401 | -3.7291 | -9.8453 | -18.382 | -14.8977 | -3.3027 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 0 | 4 | 0.9919 | 4.028 | 4.6045 | 5.0511 | -2.9992 | 4.4587 | 9.5451 | 1.8796 | -2.5145 | 6.0782 | -1.3222 | 0.9919 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.012 | IC50 | = | 12 | nM |
| 0.044 | IC50 | = | 44 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000060205 uM | Activity at 0.0000300955 uM | Activity at 0.0000624651 uM | Activity at 0.0001389779 uM | Activity at 0.0003184034 uM | Activity at 0.0006683289 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00492 uM | Activity at 0.00762 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.176 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.372 uM | Activity at 1.908 uM | Activity at 4.964 uM | Activity at 9.273 uM | Activity at 17.43 uM | Activity at 44.77 uM | Activity at 91.96 uM | Activity at 155.1 uM | Activity at 231.0 uM | Activity at 0.0000073700 uM | Activity at 0.0000316373 uM | Activity at 0.0000755538 uM | Activity at 0.0001736587 uM | Activity at 0.0003606937 uM | Activity at 0.0007618542 uM | Activity at 0.00133 uM | Activity at 0.00262 uM | Activity at 0.00635 uM | Activity at 0.00856 uM | Activity at 0.017 uM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -6.0862 | 4.9549 | 0.8467 | -19.0684 | -1.5 | 4 | 0 0 0 0 0 0 1 | 2.1181 | 0 | 0 | -8.3436 | 1.8417 | -20.8904 | -17.2092 | 2.1181 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.0937 | 0 | 4.0286 | 3.4263 | -3.4283 | 4.6593 | 0.9586 | 3.0937 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | -8.4362 | 4.9549 | 0.6002 | 0 | -10.4429 | 4 | 0 0 0 0 0 0 1 | -5.6741 | -7.869 | 4.8276 | 0 | 0 | 0 | -3.665 | -5.6741 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.2269 | 1.5944 | 0.8268 | -6.8139 | 0 | 0 | 3.009 | -1.2269 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 0.646 | |||||||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.0161 | 0 | 4.7391 | 0 | 0.5074 | 0 | 4.0037 | 2.0161 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | -58.9387 | -0.6589 | 0 | 0.7761 | -3.0501 | 0 | 0 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | -5.3862 | 3.5722 | 0.9641 | -17.9156 | 1 | 4 | 0 0 0 0 0 0 1 | 0 | 0 | 0 | 1.0595 | 3.8445 | 0 | -17.013 | 0 | |||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.6175 | 0 | 0 | 0 | 0 | -31.9156 | 4.5285 | -1.6175 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 3.582 | 6.9588 | 0 | |||||||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 4.1629 | -0.0681 | 0 | -0.134 | 0 | 3.5032 | 0 | 4.1629 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.0775 | -4.4477 | 0 | 0 | 4.2892 | -3.0832 | 0 | 0.0775 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.2864 | -6.299 | 0 | 0 | 0 | 0 | -3.464 | -4.2864 | |||||||||||||||||||||||||||||||||||||
| Inhibitor | 20.2301 | 30.4667 | 10 | Partial curve; partial efficacy; poor fit | -4.694 | 4.9549 | 0.9513 | -30.9667 | -0.5 | -2.4 | 0 0 0 0 0 0 0 | -27.4722 | 3.5967 | 1.0091 | 0 | -2.7438 | -3.3305 | -0.4297 | -27.4722 | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.3461 | 0 | ||||||||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -5.4775 | 0 | -1.3364 | 0 | 4.4063 | 0 | -3.1548 | -5.4775 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.2138 | -0.309 | 0 | -3.3277 | -5.0776 | 1.8649 | 0 | 2.2138 | |||||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -6.8569 | -2.0086 | 0 | 0 | 0 | 0 | 0 | -6.8569 | |||||||||||||||||||||||||||||||||||||
| Inhibitor | 20.2301 | 111.056 | 10 | Single point of activity | -4.694 | 4.9549 | 0.9964 | -109.5222 | 1.5338 | -3 | 0 0 0 0 0 0 0 | -97.6133 | 3.53 | 0.1744 | -1.6149 | 4.6418 | 0 | 2.914 | -97.6133 | ||||||||||||||||||||||||||||||
| Inactive | 0 | -4.694 | 4.9549 | 0.8369 | -20.4658 | 3 | 4 | 0 0 0 0 0 0 0 | -17.8882 | 2.6386 | 0 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.0078 | IC50 | = | 7.8 | nM |
| 0.003 | IC50 | = | 3 | nM |
| 0.0027 | IC50 | = | 2.7 | nM |
| 0.009 | IC50 | = | 9 | nM |
| 0.006 | IC50 | = | 6 | nM |
| 0.025 | IC50 | = | 25 | nM |
| 0.037 | IC50 | = | 37 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.0046 | IC50 | = | 4.6 | nM |
| 0.0042 | IC50 | = | 4.2 | nM |
| 0.05 | IC50 | = | 50 | nM |
| 0.004 | IC50 | = | 4 | nM |
| 0.021 | IC50 | = | 21 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 0.85 | Kd | = | 850 | nM |
| 0.064 | Kd | = | 64 | nM |
| 0.24 | Kd | = | 240 | nM |
| 1.2 | Kd | = | 1200 | nM |
| Phenotype | Analysis Comment | Activity_Score | Max_Response | Activity at 0.029 uM | Activity at 0.115 uM | Activity at 0.144 uM | Activity at 0.230 uM | Activity at 0.575 uM | Activity at 1.257 uM | Activity at 2.059 uM | Activity at 2.870 uM | Activity at 3.790 uM | Activity at 5.750 uM | Activity at 7.911 uM | Activity at 11.54 uM | Activity at 17.22 uM | Activity at 25.95 uM | Activity at 38.35 uM | Activity at 57.50 uM | Activity at 85.10 uM | Activity at 115.2 uM | Activity at 153.0 uM | Activity at 245.0 uM | Activity at 288.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -0.96 | 3.5361 | -0.96 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9559 | -3.6852 | -0.9559 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9553 | -5.7534 | -0.9553 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9545 | -5.6084 | -0.9545 | QC'd by ChemRoutes | ||||||||||||||||||||
| Inactive | 0 | -0.953 | -2.3216 | -0.953 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9492 | 2.2186 | -0.9492 | QC'd by Edelris | ||||||||||||||||||||
| Inactive | 0 | -0.9486 | -1.2758 | -0.9486 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9467 | 4.4666 | -0.9467 | QC'd by ChemRoutes | ||||||||||||||||||||
| Inactive | 0 | -0.9436 | -8.9932 | -0.9436 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9422 | -1.7826 | -0.9422 | QC'd by Analyticon | ||||||||||||||||||||
| Inactive | 0 | -0.941 | 5.2115 | -0.941 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9398 | 4.3972 | -0.9398 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9362 | 4.3836 | -0.9362 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9299 | 2.8643 | -0.9299 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9293 | 4.8772 | -0.9293 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9286 | -10.0521 | -0.9286 | QC'd by Chemdiv | ||||||||||||||||||||
| Inactive | 0 | -0.9253 | -2.1742 | -0.9253 | QC'd by Sytravon | ||||||||||||||||||||
| Inactive | 0 | -0.9204 | 0.4163 | -0.9204 | QC'd by Edelris | ||||||||||||||||||||
| Inactive | 0 | -0.9193 | -0.0183 | -0.9193 | QC'd by Analyticon | ||||||||||||||||||||
| Inactive | 0 | -0.9182 | -0.8109 | -0.9182 | QC'd by Analyticon |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -8.3213 | 4.9549 | 0.6423 | 4 | -4.8346 | 4 | 0 0 0 0 0 0 1 | -4.4443 | -2.7788 | 7.3689 | 5.3693 | 2.3397 | 3.3383 | 1.6715 | -4.4443 | QC'd by Sytravon | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 2.3919 | 69.7049 | 84 | Complete curve; high efficacy | -5.6213 | 0.9 | 0.993 | -69.4929 | 0.212 | -1.1 | 0 0 0 0 0 0 0 | -66.6604 | -0.2513 | 1.2197 | -5.3806 | -9.9311 | -37.162 | -53.3921 | -66.6604 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 9.5221 | 76.4074 | 42 | Partial curve; high efficacy | -5.0213 | 1.111 | 0.9951 | -75.9094 | 0.498 | -2.1 | 0 0 0 0 0 0 0 | -66.5912 | 3.4283 | -1.6815 | -1.5622 | -0.1199 | -13.7121 | -41.7015 | -66.5912 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.5213 | 1.7529 | 0.9212 | -24.9877 | 5.5 | 4 | 0 0 0 0 0 0 0 | -17.4897 | 7.3623 | 2.4616 | 9.8416 | 3.3605 | 3.9651 | 0.8896 | -17.4897 | QC'd by Sytravon | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 1.5092 | 115.264 | 87 | Complete curve; high efficacy | -5.8213 | 1.4641 | 0.9934 | -109.8568 | 5.4073 | -1.1 | 0 0 0 0 0 0 0 | -110.2979 | -0.8149 | 9.8634 | 3.518 | -7.3368 | -73.6123 | -100.848 | -110.2979 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.6933 | 117.9781 | 87 | Complete curve; high efficacy | -5.7713 | 4.5045 | 0.9912 | -112.73 | 5.2481 | -1.1 | 0 0 0 0 0 0 0 | -115.2658 | 15.9372 | 2.4103 | -1.2409 | 2.2518 | -88.9575 | -109.7932 | -115.2658 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 4.7724 | 81.2956 | 43 | Partial curve; high efficacy | -5.3213 | 1 | 0.9946 | -78.6057 | 2.6899 | -2.1 | 0 0 0 0 0 0 0 | -71.671 | -0.6447 | 6.4302 | 0.1885 | -3.4582 | -24.3313 | -55.7062 | -71.671 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 94.3951 | 83 | Complete curve; high efficacy | -5.1213 | 4.9549 | 0.9967 | -94.6258 | -0.2307 | -1.1 | 0 0 0 0 0 0 0 | -93.8748 | 3.4317 | -2.5012 | -1.7201 | -2.4455 | 2.6182 | -85.3984 | -93.8748 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.6837 | 65.0297 | 84 | Complete curve; high efficacy | -5.5713 | 4.095 | 0.989 | -65.3833 | -0.3537 | -1.1 | 0 0 0 0 0 0 0 | -70.4739 | -2.312 | -0.8042 | -1.2281 | 3.0628 | -22.6396 | -60.696 | -70.4739 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 57.2061 | 42 | Partial curve; partial efficacy | -5.1213 | 1.6259 | 0.9942 | -54.1319 | 3.0742 | -2.2 | 0 0 0 0 0 0 0 | -52.3087 | 6.207 | 2.8252 | 1.4762 | 0.0987 | -3.9796 | -35.0702 | -52.3087 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.1988 | 74.6197 | 85 | Complete curve; high efficacy | -5.9213 | 1.1341 | 0.9933 | -70.9204 | 3.6993 | -1.1 | 0 0 0 0 0 0 0 | -71.4906 | 4.2219 | -0.1886 | 4.5237 | -17.1469 | -46.9199 | -63.4145 | -71.4906 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.1317 | 118.4516 | 86 | Complete curve; high efficacy | -5.6713 | 2.7202 | 0.993 | -110.0886 | 8.3631 | -1.1 | 0 0 0 0 0 0 0 | -116.1272 | 7.5782 | 5.1028 | 5.8814 | 12.5352 | -56.6231 | -102.2879 | -116.1272 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 2.1317 | 122.7031 | 87 | Complete curve; high efficacy | -5.6713 | 2.4064 | 0.9787 | -115.7272 | 6.9759 | -1.1 | 0 0 0 0 0 0 0 | -122.0751 | 3.8589 | 17.443 | -6.0833 | 11.7009 | -62.2871 | -106.7609 | -122.0751 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 6.7412 | 121.0829 | 84 | Complete curve; high efficacy | -5.1713 | 4.095 | 0.9954 | -126.4671 | -5.3842 | -1.1 | 0 0 0 0 0 0 0 | -126.975 | -0.8069 | -3.4445 | -2.4548 | -11.8834 | -10.2564 | -113.7668 | -126.975 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 4.7724 | 86.827 | 44 | Partial curve; high efficacy | -5.3213 | 1 | 0.9941 | -85.383 | 1.444 | -2.1 | 0 0 0 0 0 0 0 | -78.6992 | -2.4316 | 1.8612 | -0.004 | -1.8987 | -28.5107 | -58.6303 | -78.6992 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 125.154 | 84 | Complete curve; high efficacy | -5.1213 | 3.9295 | 0.9979 | -122.5872 | 2.5668 | -1.1 | 0 0 0 0 0 0 0 | -123.0795 | 3.0986 | 3.1267 | 1.8871 | -2.1093 | 5.2605 | -101.0355 | -123.0795 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 0.6741 | 119.9199 | 89 | Complete curve; high efficacy | -6.1713 | 1.3723 | 0.9986 | -109.7454 | 10.1745 | -1.1 | 0 0 0 0 0 0 0 | -110.854 | 8.8459 | 7.7415 | 6.7576 | -35.5397 | -88.9969 | -106.7803 | -110.854 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 6.7412 | 115.9813 | 84 | Complete curve; high efficacy | -5.1713 | 2.3031 | 0.9963 | -113.5967 | 2.3846 | -1.1 | 0 0 0 0 0 0 0 | -113.37 | -1.2322 | -1.5984 | 5.8599 | 5.7708 | -6.0722 | -86.9448 | -113.37 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 1.5092 | 114.0509 | 88 | Complete curve; high efficacy | -5.8213 | 1.9673 | 0.9946 | -113.9158 | 0.1351 | -1.1 | 0 0 0 0 0 0 0 | -113.0117 | -0.8223 | -4.0553 | -2.3728 | -1.6822 | -81.3904 | -111.2484 | -113.0117 | QC'd by Sytravon | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 8.4866 | 60.7927 | 42 | Partial curve; partial efficacy | -5.0713 | 2.4064 | 0.9868 | -57.9639 | 2.8287 | -2.2 | 0 0 0 0 0 0 0 | -56.5473 | 6.8781 | 4.8766 | 1.3348 | -2.2008 | 1.3516 | -39.1581 | -56.5473 | QC'd by Sytravon | 0 |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | -7.26 | 0.7 | 0.9831 | 22 | 0 | 4 | 0 0 0 0 0 0 0 0 | 18.7243 | 0.7509 | 0.7403 | 0.1615 | 0.2208 | 2.5712 | 9.0624 | 12.4905 | 18.7243 | QC'd by Labotest | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.0813 | 2.9095 | 4.1819 | 3.0683 | 1.5475 | 1.9993 | -1.4829 | 3.8282 | 3.0813 | QC'd by Labotest | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 10.964 | 62.6971 | 10 | Partial curve; high efficacy; poor fit | -4.96 | 4.9549 | 0.998 | -66.9977 | -4.3007 | -2.3 | 1 0 0 0 0 0 0 0 | -65.7875 | -42.8846 | -3.6636 | -4.8429 | -3.3836 | -3.8623 | -4.4736 | -41.4229 | -65.7875 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||
| Inhibitor | 38.9018 | 33.8501 | 10 | Partial curve; partial efficacy; poor fit | -4.41 | 4.9549 | 0.924 | -33.3501 | 0.5 | -2.4 | 0 0 0 0 0 0 0 0 | -29.0418 | -1.5551 | 0.5206 | 0.875 | -1.2476 | -0.5605 | -1.8092 | 7.4199 | -29.0418 | QC'd by SIGMA | 0 | |||||||||||||||||||||||||||
| Inhibitor | 1.7377 | 81.2298 | 85 | Complete curve; high efficacy | -5.76 | 1.9673 | 0.9976 | -79.9564 | 1.2734 | -1.1 | 0 0 0 0 0 0 0 0 | -78.332 | 4.4795 | 0.7606 | 0.0181 | -0.701 | -3.7995 | -49.0322 | -80.0522 | -78.332 | QC'd by Tocris | 0 | |||||||||||||||||||||||||||
| Inhibitor | 34.6713 | 37.2317 | 10 | Partial curve; partial efficacy; poor fit | -4.46 | 2.3531 | 0.9195 | -37.2317 | 0 | -2.4 | 0 0 0 0 0 0 0 0 | -28.5264 | 3.9692 | 5.0423 | -3.0201 | -3.1048 | -1.1738 | -0.8348 | -2.4447 | -28.5264 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||
| Inhibitor | 15.4871 | 71.273 | 41 | Partial curve; high efficacy | -4.81 | 1.4487 | 0.9928 | -70.4113 | 0.8617 | -2.1 | 0 0 0 0 0 0 0 0 | -61.7643 | 0.2853 | 1.9381 | -1.2811 | -0.3436 | 4.6186 | -4.2001 | -27.4432 | -61.7643 | QC'd by GVK | 0 | |||||||||||||||||||||||||||
| Inhibitor | 0.2188 | 91.9728 | 90 | Complete curve; high efficacy | -6.66 | 0.8 | 0.9894 | -90.0102 | 1.9626 | -1.1 | 0 0 0 0 0 0 0 0 | -83.8769 | 2.7707 | 0.8657 | -14.6874 | -27.4321 | -55.0254 | -79.0233 | -92.6031 | -83.8769 | QC'd by Prestwick Chemical; Inc. | 0 | |||||||||||||||||||||||||||
| Inhibitor | 34.6713 | 45.8288 | 10 | Single point of activity | -4.46 | 2.3531 | 0.9938 | -45.8288 | 0 | -3 | 0 0 0 0 0 0 0 0 | -35.0976 | -0.4182 | -0.112 | -0.9148 | 2.1786 | -0.5211 | -0.77 | -3.3082 | -35.0976 | QC'd by Vitas | 0 | |||||||||||||||||||||||||||
| Inhibitor | 13.8029 | 116.5981 | 42 | Partial curve; high efficacy | -4.86 | 0.7 | 0.9704 | -115.474 | 1.1242 | -2.1 | 0 0 0 0 0 0 0 0 | -87.4803 | -1.207 | 1.2781 | -1.1552 | -1.0641 | -0.761 | -34.877 | -47.6739 | -87.4803 | QC'd by Vitas | 0 | |||||||||||||||||||||||||||
| Inhibitor | 19.4971 | 71.1695 | 41 | Partial curve; high efficacy | -4.71 | 2.3332 | 0.9649 | -71.6292 | -0.4597 | -2.1 | 0 0 0 0 0 0 0 0 | -66.007 | -7.507 | 3.5896 | -6.5823 | 3.2102 | 2.0494 | 2.4442 | -17.4355 | -66.007 | QC'd by Enzo | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -0.3397 | 0.6834 | 1.1935 | -3.1601 | -7.1353 | -6.692 | -3.5353 | -4.6055 | -0.3397 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 38.9018 | 99.7077 | 10 | Single point of activity | -4.41 | 2.9023 | 0.9979 | -103.2475 | -3.5398 | -3 | 0 0 0 0 0 0 0 0 | -78.9754 | -2.6538 | -1.9475 | -2.4198 | -3.036 | -5.7354 | -4.4174 | -6.1242 | -78.9754 | QC'd by Labotest | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.5579 | 4.2966 | 3.8697 | 0.914 | 1.5784 | 2.7763 | 2.2827 | -0.2746 | 0.5579 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.2893 | 4.5048 | 5.9389 | 2.7905 | 6.1256 | 1.1364 | 5.7573 | 5.7586 | -2.2893 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||||||||
| Inhibitor | 12.3018 | 42.2827 | 21 | Partial curve; partial efficacy | -4.91 | 2.3332 | 0.9667 | -45.1528 | -2.8702 | -2.2 | 0 0 0 0 0 0 0 0 | -43.5551 | -8.1379 | -5.4062 | -0.9215 | 0.1464 | -0.2747 | -3.1761 | -22.7908 | -43.5551 | QC'd by Labotest | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.7074 | -0.3729 | 0.324 | 2.0766 | 2.6464 | 1.1615 | -0.7088 | 4.4781 | 2.7074 | QC'd by Prestwick | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -1.9964 | 3.7048 | 1.6527 | 3.6208 | 3.1922 | 5.0362 | 4.9342 | -1.7586 | -1.9964 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||||||||
| Inactive | 0 | -6.36 | 0.8 | 0.8961 | 5 | -7.0477 | 4 | 0 0 0 0 0 0 0 0 | 4.9227 | -4.8515 | -7.6164 | -8.7898 | -3.2699 | 0.2917 | 0.3418 | 5.5058 | 4.9227 | QC'd by Vitas | Inactive | 0 | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 3.4671 | 109.1625 | 45 | Partial curve; high efficacy | -5.46 | 0.9 | 0.9982 | -103.5313 | 5.6312 | -2.1 | 0 0 0 0 0 0 0 0 | -96.3979 | 5.9869 | 3.177 | 3.4783 | 4.7559 | -9.3266 | -39.4946 | -74.1667 | -96.3979 | QC'd by Enzo | 0 |
| Phenotype | Potency | Efficacy | Analysis Comment | vec-Activity_Score | vec-Curve_Description | vec-Fit_LogAC50 | vec-Fit_HillSlope | vec-Fit_R2 | vec-Fit_InfiniteActivity | vec-Fit_ZeroActivity | vec-Fit_CurveClass | vec-Excluded_Points | vec-Max_Response | vec-Activity at 0.0001672135 uM | vec-Activity at 0.0002575382 uM | vec-Activity at 0.0005016404 uM | vec-Activity at 0.0007801051 uM | vec-Activity at 0.00152 uM | vec-Activity at 0.00234 uM | vec-Activity at 0.00456 uM | vec-Activity at 0.00702 uM | vec-Activity at 0.014 uM | vec-Activity at 0.021 uM | vec-Activity at 0.041 uM | vec-Activity at 0.063 uM | vec-Activity at 0.123 uM | vec-Activity at 0.190 uM | vec-Activity at 0.332 uM | vec-Activity at 0.562 uM | vec-Activity at 0.995 uM | vec-Activity at 1.687 uM | vec-Activity at 2.986 uM | vec-Activity at 5.062 uM | vec-Activity at 8.957 uM | vec-Activity at 15.19 uM | vec-Activity at 30.72 uM | vec-Activity at 46.08 uM | vec-Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.1663 | 93.7154 | 91 | Complete curve; high efficacy | -6.7792 | 1.8617 | 0.9983 | -94.3026 | -0.5872 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.836 | -4.3648 | -1.0748 | -0.5518 | 0.0356 | -14.8265 | -51.0387 | -84.7502 | -91.6605 | -94.0969 | -95.7144 | -95.836 | QC'd by Aobious | |||||||||||||||
| Inhibitor | 0.1865 | 85.0956 | 90 | Complete curve; high efficacy | -6.7292 | 3.0654 | 0.9884 | -87.5609 | -2.4652 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -77.6886 | -5.973 | -3.805 | -0.6091 | -2.0476 | -1.614 | -49.4029 | -87.6042 | -91.431 | -92.9521 | -84.0528 | -77.6886 | QC'd by JohnsHopkins | |||||||||||||||
| Inhibitor | 0.2349 | 90.5432 | 89 | Complete curve; high efficacy | -6.6292 | 0.9 | 0.9865 | -85.0679 | 5.4753 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -85.4463 | 4.5673 | 0 | 0 | 3.5991 | -12.5698 | -43.6526 | -53.391 | -71.2936 | -75.2981 | -85.9272 | -85.4463 | QC'd by ChemieTek | |||||||||||||||
| Inhibitor | 0.2635 | 80.6141 | 88 | Complete curve; high efficacy | -6.5792 | 4.9549 | 0.9945 | -80.5584 | 0.0557 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -72.7514 | 0 | 0 | 0 | 0 | 0 | -11.8715 | -82.3 | -80.0493 | -82.2426 | -84.4428 | -72.7514 | QC'd by JohnsHopkins | |||||||||||||||
| Inhibitor | 0.5899 | 88.053 | 87 | Complete curve; high efficacy | -6.2292 | 1.8265 | 0.975 | -84.536 | 3.517 | -1.1 | 0 0 1 0 0 0 0 0 0 0 0 | -96.5023 | 0 | 3.1333 | -41.798 | 0 | 3.9829 | 0.0582 | -36.9935 | -80.5426 | -73.0641 | -78.4789 | -96.5023 | QC'd by FLUKA | |||||||||||||||
| Inhibitor | 1.4818 | 88.4995 | 86 | Complete curve; high efficacy | -5.8292 | 3.0654 | 0.9925 | -91.3736 | -2.8741 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -92.2965 | -10.3451 | -5.2949 | -5.3606 | -0.0879 | 1.4443 | -3.5805 | -2.5611 | -54.15 | -89.0032 | -92.2351 | -92.2965 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 2.6351 | 92.0449 | 85 | Complete curve; high efficacy | -5.5792 | 0.9 | 0.9854 | -88.8731 | 3.1719 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -82.1008 | 4.4621 | 0 | 0 | 0 | 0 | 1.1677 | -9.9743 | -41.1887 | -56.1612 | -69.0144 | -82.1008 | QC'd by Cayman | |||||||||||||||
| Inhibitor | 3.3174 | 91.035 | 84 | Complete curve; high efficacy | -5.4792 | 1.1 | 0.9864 | -88.7059 | 2.3291 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -86.9666 | 0.4162 | 4.742 | 0 | 0 | 0 | 0 | -1.6346 | -34.216 | -52.0066 | -70.7804 | -86.9666 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 0.0074 | 76.0879 | 72 | Complete curve; partial efficacy | -8.1292 | 1.01 | 0.9221 | -68.5599 | 7.528 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -69.6778 | 3.1905 | -10.7774 | -35.3184 | -33.3051 | -76.5293 | -67.2894 | -66.6112 | -65.0938 | -64.7844 | -66.9312 | -69.6778 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 0.0418 | 74.4709 | 71 | Complete curve; partial efficacy | -7.3792 | 4.5045 | 0.9566 | -73.5473 | 0.9235 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -95.7648 | 0 | 0 | 0 | 0 | -63.3752 | -67.7485 | -71.6624 | -69.9653 | -67.7118 | -68.9474 | -95.7648 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 0.0418 | 64.4317 | 71 | Complete curve; partial efficacy | -7.3792 | 0.5 | 0.9783 | -75.5148 | -11.0831 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.9907 | -19.41 | -24.9563 | -24.8097 | -39.743 | -50.5208 | -54.7625 | -57.292 | -63.9683 | -74.1358 | -72.7363 | -72.9907 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 0.0935 | 62.6526 | 70 | Complete curve; partial efficacy | -7.0292 | 2.3332 | 0.9924 | -75.7054 | -13.0527 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -76.0436 | -9.0427 | -19.821 | -10.6946 | -15.0284 | -31.5928 | -66.1348 | -74.4881 | -76.0574 | -74.9286 | -75.5779 | -76.0436 | QC'd by DC Chemicals | |||||||||||||||
| Inhibitor | 0.0418 | 58.4453 | 69 | Complete curve; partial efficacy | -7.3792 | 2.4064 | 0.9701 | -63.8808 | -5.4355 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -74.355 | -11.6467 | -6.1795 | 0 | -14.1061 | -48.2925 | -56.4852 | -60.8603 | -64.733 | -63.9392 | -62.5512 | -74.355 | QC'd by Glixx | |||||||||||||||
| Inhibitor | 0.3317 | 84.5367 | 68 | Complete curve; partial efficacy | -6.4792 | 0.8 | 0.9582 | -78.989 | 5.5477 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -81.0083 | 1.5354 | 1.1386 | 3.515 | 2.4799 | -10.1697 | -34.367 | -38.5203 | -71.1794 | -55.8536 | -78.8627 | -81.0083 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 0.0888 | 60.4 | 68 | Complete curve; partial efficacy | -7.0517 | 1.1 | 0.8857 | -64.3669 | -3.9668 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -69.7841 | 3.2929 | -0.2156 | -29.0492 | 4.8843 | -6.5124 | -28.0314 | -43.9523 | -52.8325 | -56.4725 | -63.4938 | -69.7841 | QC'd by Analyticon | |||||||||||||||
| Inhibitor | 0.1049 | 65.9409 | 68 | Complete curve; partial efficacy | -6.9792 | 1.2221 | 0.9818 | -61.4449 | 4.496 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -65.6897 | 0 | 3.6673 | 4.39 | 2.7152 | -23.4918 | -42.1256 | -47.8291 | -60.452 | -58.1118 | -61.4201 | -65.6897 | QC'd by DC Chemicals | |||||||||||||||
| Inhibitor | 0.0526 | 62.2806 | 68 | Complete curve; partial efficacy | -7.2792 | 3.9295 | 0.9705 | -60.668 | 1.6127 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -73.52 | 0 | 0 | 0 | 4.2268 | -41.0488 | -54.3132 | -54.239 | -59.1006 | -59.3125 | -62.6673 | -73.52 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 0.4686 | 76.3052 | 67 | Complete curve; partial efficacy | -6.3292 | 3.0654 | 0.9976 | -74.3129 | 1.9923 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -75.103 | 0 | 0 | 1.3012 | 2.3757 | 3.9376 | 0 | -47.9131 | -70.1927 | -73.0559 | -76.2157 | -75.103 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 0.3317 | 72.1533 | 67 | Complete curve; partial efficacy | -6.4792 | 1.8617 | 0.976 | -71.7259 | 0.4274 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -76.1351 | -3.0909 | -6.3525 | 3.2689 | 4.0679 | 4.5914 | -23.4463 | -48.0275 | -74.6919 | -68.5927 | -65.3693 | -76.1351 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 0.3534 | 64.6877 | 66 | Complete curve; partial efficacy | -6.4517 | 4.9549 | 0.9993 | -64.7841 | -0.0965 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -65.2761 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -47.254 | -62.6419 | -65.9648 | -65.2761 | QC'd by Analyticon |
| Phenotype-Replicate_1 | Potency-Replicate_1 | Efficacy-Replicate_1 | Analysis Comment-Replicate_1 | Activity_Score-Replicate_1 | Curve_Description-Replicate_1 | Fit_LogAC50-Replicate_1 | Fit_HillSlope-Replicate_1 | Fit_R2-Replicate_1 | Fit_InfiniteActivity-Replicate_1 | Fit_ZeroActivity-Replicate_1 | Fit_CurveClass-Replicate_1 | Excluded_Points-Replicate_1 | Max_Response-Replicate_1 | Activity at 0.0000073560 uM-Replicate_1 | Activity at 0.0000367800 uM-Replicate_1 | Activity at 0.0000735600 uM-Replicate_1 | Activity at 0.0001677464 uM-Replicate_1 | Activity at 0.0003678000 uM-Replicate_1 | Activity at 0.0007362988 uM-Replicate_1 | Activity at 0.00153 uM-Replicate_1 | Activity at 0.00368 uM-Replicate_1 | Activity at 0.00723 uM-Replicate_1 | Activity at 0.00914 uM-Replicate_1 | Activity at 0.018 uM-Replicate_1 | Activity at 0.039 uM-Replicate_1 | Activity at 0.092 uM-Replicate_1 | Activity at 0.191 uM-Replicate_1 | Activity at 0.460 uM-Replicate_1 | Activity at 0.910 uM-Replicate_1 | Activity at 1.182 uM-Replicate_1 | Activity at 2.302 uM-Replicate_1 | Activity at 4.834 uM-Replicate_1 | Activity at 11.49 uM-Replicate_1 | Activity at 23.94 uM-Replicate_1 | Activity at 57.45 uM-Replicate_1 | Activity at 115.4 uM-Replicate_1 | Activity at 193.5 uM-Replicate_1 | Activity at 288.3 uM-Replicate_1 | Compound QC-Replicate_1 | Phenotype-Replicate_2 | Potency-Replicate_2 | Efficacy-Replicate_2 | Analysis Comment-Replicate_2 | Activity_Score-Replicate_2 | Curve_Description-Replicate_2 | Fit_LogAC50-Replicate_2 | Fit_HillSlope-Replicate_2 | Fit_R2-Replicate_2 | Fit_InfiniteActivity-Replicate_2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 21.3174 | 85.5207 | 41 | Partial curve; high efficacy | -4.6713 | 3.1925 | 0.957 | -74.5207 | 11 | -2.1 | 0 0 0 0 0 0 0 | -71.2673 | 6.6581 | 8.6616 | 5.0342 | 9.0296 | 24.6831 | 0.5948 | -71.2673 | QC'd by Microsource | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.3186 | 7.062 | 5.197 | 5.6925 | 7.2359 | 1.267 | 0.5201 | 0.3186 | QC'd by Microsource | 0 | |||||||||||||||||||||||||||||||||||
| Inhibitor | 7.5637 | 93.5447 | 43 | Partial curve; high efficacy | -5.1213 | 1.9282 | 0.9984 | -89.2795 | 4.2653 | -2.1 | 0 0 0 0 0 0 0 | -87.5289 | 7.1656 | 5.0788 | 2.7979 | 2.1575 | -3.7741 | -60.4613 | -87.5289 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 48.6356 | 10 | Single point of activity | -4.5713 | 2.2481 | 0.9788 | -42.8484 | 5.7872 | -3 | 0 0 0 0 0 0 0 | -35.4677 | 5.9629 | 5.4796 | 2.7092 | 10.2755 | 4.6543 | -0.1967 | -35.4677 | QC'd by NCI | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 8.4866 | 130.7668 | 43 | Partial curve; high efficacy | -5.0713 | 1 | 0.9992 | -119.8967 | 10.8701 | -2.1 | 0 0 0 0 0 0 0 | -102.4758 | 11.9466 | 11.2427 | 7.1554 | 5.0781 | -16.0537 | -65.0649 | -102.4758 | QC'd by BIOMOL | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 5.3547 | 99.1896 | 44 | Partial curve; high efficacy | -5.2713 | 0.9 | 0.9888 | -96.5712 | 2.6185 | -2.1 | 0 0 0 0 0 0 0 | -87.001 | -0.2592 | -1.637 | 6.8143 | -4.5159 | -32.2161 | -61.4841 | -87.001 | QC'd by BIOMOL | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.6713 | 2.3332 | 0.6923 | -15.1448 | -0.5 | 4 | 0 0 0 0 0 0 0 | -13.8707 | -3.7401 | -1.2778 | 5.1005 | -4.6904 | 1.916 | -3.5213 | -13.8707 | QC'd by InterBioScreen | 0 | |||||||||||||||||||||||||||||||
| Inhibitor | 25.4012 | 56.2022 | 40 | Partial curve; partial efficacy | -4.5951 | 4.5045 | 0.9727 | -57.7888 | -1.5865 | -2.2 | 0 0 0 0 0 0 0 0 | -57.6748 | -1.4876 | -4.4957 | -6.2296 | 2.8676 | 3.1906 | -3.7494 | -18.0858 | -57.6748 | QC'd by LightBiologicals | Inhibitor | 40.2582 | 41.121 | 10 | Single point of activity | -4.3951 | 2.9523 | 0.943 | -42.7254 | |||||||||||||||||||
| Inhibitor | 7.5637 | 97.4712 | 43 | Partial curve; high efficacy | -5.1213 | 1.9282 | 0.9955 | -91.4517 | 6.0195 | -2.1 | 0 0 0 0 0 0 0 | -89.1342 | 6.428 | 11.1902 | 4.9868 | 1.8065 | -2.3315 | -62.2028 | -89.1342 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 21.3174 | 76.6638 | 41 | Partial curve; partial efficacy | -4.6713 | 1.2475 | 0.9713 | -70.1638 | 6.5 | -2.2 | 0 0 0 0 0 0 0 | -53.0597 | 11.8628 | 10.1962 | -0.3079 | 4.293 | 1.9517 | -17.9254 | -53.0597 | QC'd by SigmaAldrich | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 101.6656 | 40 | Partial curve; high efficacy | -4.5713 | 1.5936 | 0.9916 | -96.2704 | 5.3952 | -2.1 | 0 0 0 0 0 0 0 | -73.3109 | 5.6238 | 8.7858 | 6.2448 | 2.4666 | -0.9326 | -13.5438 | -73.3109 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 3.7908 | 87.1465 | 44 | Partial curve; high efficacy | -5.4213 | 0.8 | 0.9942 | -85.1952 | 1.9512 | -2.1 | 0 0 0 0 0 0 0 | -78.8845 | 1.4625 | -1.8716 | 1.6032 | -10.9203 | -35.4628 | -58.552 | -78.8845 | QC'd by Tocris | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 37.9083 | 129.9148 | 10 | Single point of activity | -4.4213 | 4.9549 | 0.9896 | -129.2975 | 0.6173 | -3 | 0 0 0 0 0 0 0 | -114.6255 | -1.4437 | -2.5082 | -0.9019 | 8.8381 | -4.5458 | 3.1106 | -114.6255 | QC'd by SigmaAldrich | 0 | ||||||||||||||||||||||||||||
| Inhibitor | 26.837 | 109.0621 | 40 | Partial curve; high efficacy | -4.5713 | 1.3437 | 0.9459 | -109.3538 | -0.2917 | -2.1 | 0 0 0 0 0 0 0 | -82.8438 | 2.5325 | 5.0732 | 0.7828 | 0.5149 | -19.3744 | -20.4297 | -82.8438 | QC'd by Bosche | 0 | ||||||||||||||||||||||||||||
| Inactive | 0 | -4.41 | 2.9023 | 0.8395 | -17.3952 | -0.5 | 4 | 0 0 0 0 0 0 0 0 | -13.246 | -3.8469 | 1.9539 | -0.2562 | -2.6537 | 1.477 | 0.7446 | -0.9487 | -13.246 | QC'd by ACC | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | -8.36 | 3.132 | 0.3628 | 3 | -4.5164 | 4 | 0 0 0 0 0 0 0 0 | 2.109 | -4.1803 | -1.8377 | 5.2557 | -1.0504 | 8.3001 | -3.1085 | 6.745 | 2.109 | QC'd by Pharmaron | 0 | ||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.5041 | -8.5785 | 2.7045 | 0.1138 | -10.5842 | 0.9358 | 2.0884 | 0.5041 | QC'd by Toronto Research | 0 | |||||||||||||||||||||||||||||||||||
| Inhibitor | 44.4932 | 35.2765 | 10 | Single point of activity | -4.3517 | 3.6772 | 0.8478 | -34.7273 | 0.5492 | -3 | 0 0 0 0 0 0 0 0 | -32.3137 | -1.4989 | -3.7044 | -1.139 | -0.4924 | 12.1946 | -1.1884 | -3.139 | -32.3137 | QC'd by RTI | 0 | |||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 6.6308 | 7.6331 | 6.024 | 7.3986 | 0.2263 | 3.1874 | 3.4285 | 6.6308 | QC'd by Tocris | 0 | |||||||||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 5.3261 | 12.5764 | 10.1122 | 11.5363 | 11.262 | 7.195 | 3.9591 | 5.3261 | QC'd by NCGCChem | 0 |
| Phenotype | Potency | Efficacy | Analysis Comment | MDR-19-Activity_Score | MDR-19-Curve_Description | MDR-19-Fit_LogAC50 | MDR-19-Fit_HillSlope | MDR-19-Fit_R2 | MDR-19-Fit_InfiniteActivity | MDR-19-Fit_ZeroActivity | MDR-19-Fit_CurveClass | MDR-19-Excluded_Points | MDR-19-Max_Response | MDR-19-Activity at 0.0001672135 uM | MDR-19-Activity at 0.0002575382 uM | MDR-19-Activity at 0.0005016404 uM | MDR-19-Activity at 0.0007801051 uM | MDR-19-Activity at 0.00152 uM | MDR-19-Activity at 0.00234 uM | MDR-19-Activity at 0.00456 uM | MDR-19-Activity at 0.00702 uM | MDR-19-Activity at 0.014 uM | MDR-19-Activity at 0.021 uM | MDR-19-Activity at 0.041 uM | MDR-19-Activity at 0.063 uM | MDR-19-Activity at 0.123 uM | MDR-19-Activity at 0.190 uM | MDR-19-Activity at 0.332 uM | MDR-19-Activity at 0.562 uM | MDR-19-Activity at 0.995 uM | MDR-19-Activity at 1.687 uM | MDR-19-Activity at 2.986 uM | MDR-19-Activity at 5.062 uM | MDR-19-Activity at 8.957 uM | MDR-19-Activity at 15.19 uM | MDR-19-Activity at 30.72 uM | MDR-19-Activity at 46.08 uM | MDR-19-Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 4.6859 | 91.0884 | 84 | Complete curve; high efficacy | -5.3292 | 2.8473 | 0.993 | -89.4324 | 1.656 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3379 | 0 | 0 | 0 | 0 | 3.5009 | -0.4666 | 4.1023 | -0.1348 | -49.9217 | -80.5716 | -94.3379 | QC'd by FLUKA | |||||||||||||||
| Inhibitor | 3.7221 | 93.1682 | 84 | Complete curve; high efficacy | -5.4292 | 2.8473 | 0.9992 | -92.1734 | 0.9948 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.3543 | 0 | 0.8156 | 0 | 1.3317 | 3.6103 | 0 | 0 | -8.2494 | -66.1556 | -91.4418 | -91.3543 | QC'd by BIOMOL | |||||||||||||||
| Inhibitor | 3.7221 | 82.363 | 84 | Complete curve; high efficacy | -5.4292 | 4.9549 | 0.9958 | -80.6599 | 1.7031 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -84.0207 | 2.4779 | 3.9479 | 3.6668 | 3.8903 | 0 | 0 | 0 | 0 | -68.2038 | -76.1871 | -84.0207 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 4.1763 | 89.769 | 84 | Complete curve; high efficacy | -5.3792 | 3.132 | 0.9943 | -91.506 | -1.737 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.2426 | -5.3545 | 0.2317 | 2.1275 | 1.5999 | -4.8836 | -0.2219 | -5.177 | -4.5459 | -63.3148 | -89.5967 | -90.2426 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 3.7221 | 70.6465 | 84 | Complete curve; high efficacy | -5.4292 | 4.9549 | 0.9893 | -80.2773 | -9.6308 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -80.0678 | -16.9708 | -11.78 | -9.4932 | -10.3981 | -9.7527 | -7.6974 | -5.5673 | -6.5049 | -70.2403 | -79.2144 | -80.0678 | QC'd by DC Chemicals | |||||||||||||||
| Inhibitor | 5.3955 | 85.6804 | 83 | Complete curve; high efficacy | -5.268 | 1.21 | 0.9845 | -83.0776 | 2.6028 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -81.014 | 0.7557 | 2.9583 | 2.5689 | 0 | 1.7234 | 0 | 0 | -36.236 | -52.6795 | -70.3074 | -81.014 | QC'd by Tocris | |||||||||||||||
| Inhibitor | 0.4686 | 71.6635 | 66 | Complete curve; partial efficacy | -6.3292 | 2.3332 | 0.9802 | -70.2285 | 1.435 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -67.6729 | 0 | 2.0506 | 0 | 3.9493 | 4.1153 | -13.211 | -38.237 | -77.1848 | -70.7851 | -64.1866 | -67.6729 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 2.9566 | 70.9093 | 64 | Complete curve; partial efficacy | -5.5292 | 4.5045 | 0.9921 | -69.8467 | 1.0627 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -75.7839 | 1.2203 | 3.2295 | 3.5894 | 0 | 0 | 0 | 0 | -3.974 | -63.2704 | -64.3995 | -75.7839 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 5.2577 | 69.4144 | 63 | Complete curve; partial efficacy | -5.2792 | 2.7868 | 0.9964 | -68.6452 | 0.7692 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -71.2208 | 1.0872 | 0 | 0 | 0 | 0.5202 | 0 | 0 | 0.6681 | -33.3572 | -62.3065 | -71.2208 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 8.3328 | 69.6852 | 62 | Complete curve; partial efficacy | -5.0792 | 1.4641 | 0.9807 | -80.2264 | -10.5412 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -72.52 | -9.54 | -6.6265 | -9.4651 | -8.8642 | -9.2851 | -14.2468 | -16.6622 | -19.7112 | -29.5294 | -63.9949 | -72.52 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 2.3485 | 90.1745 | 45 | Partial curve; high efficacy | -5.6292 | 0.8 | 0.9731 | -85.5703 | 4.6042 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -82.9923 | 4.186 | 4.9231 | 0 | 0 | 1.6049 | 2.4036 | -16.2262 | -44.8575 | -49.9704 | -63.1964 | -82.9923 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 13.2067 | 127.6308 | 42 | Partial curve; high efficacy | -4.8792 | 0.5 | 0.9098 | -124.4407 | 3.1901 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.2732 | 0 | 0 | 3.8261 | 0 | 0 | -8.7319 | -28.9296 | -36.6507 | -43.5509 | -42.4859 | -94.2732 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 13.2067 | 95.3282 | 42 | Partial curve; partial efficacy | -4.8792 | 1.111 | 0.9939 | -94.6869 | 0.6413 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -77.1324 | 0 | 1.4545 | 0 | 0 | 0 | 0 | 0.8037 | -7.768 | -27.6156 | -47.16 | -77.1324 | QC'd by SynKinase | |||||||||||||||
| Inhibitor | 14.8181 | 116.9761 | 42 | Partial curve; high efficacy | -4.8292 | 0.5 | 0.8758 | -119.758 | -2.7819 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.7258 | -11.5718 | -4.1515 | -1.8292 | -8.2684 | 2.093 | -5.6281 | -35.5981 | -40.886 | -42.0003 | -46.4747 | -90.7258 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 7.4267 | 72.9706 | 42 | Partial curve; partial efficacy | -5.1292 | 1.6266 | 0.9841 | -72.1215 | 0.8491 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -66.7587 | -0.9319 | 4.7505 | -2.2582 | -1.4348 | -1.2326 | -0.8283 | 3.2245 | -0.8234 | -28.6214 | -52.1226 | -66.7587 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 11.7705 | 83.5206 | 42 | Partial curve; partial efficacy | -4.9292 | 1.2475 | 0.9845 | -81.3899 | 2.1307 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -69.3571 | 0 | 4.3364 | 0 | 2.6674 | 0 | 0 | 0 | 1.6813 | -24.11 | -43.7186 | -69.3571 | QC'd by DC Chemicals | |||||||||||||||
| Inhibitor | 0.1177 | 60.9794 | 27 | Complete curve; partial efficacy | -6.9292 | 2.5884 | 0.9973 | -57.1621 | 3.8173 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -58.7667 | 3.4871 | 1.925 | 4.7082 | 3.7336 | -5.2519 | -43.6709 | -54.6471 | -53.9467 | -57.4511 | -58.9464 | -58.7667 | QC'd by Prestwick | |||||||||||||||
| Inhibitor | 0.6619 | 62.3862 | 25 | Complete curve; partial efficacy | -6.1792 | 1.8851 | 0.9942 | -60.2798 | 2.1064 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -60.6498 | -1.3953 | 2.273 | 3.2862 | -0.7864 | 2.8054 | 0.3723 | -24.1865 | -54.1342 | -57.2946 | -59.3161 | -60.6498 | QC'd by JohnsHopkins | |||||||||||||||
| Inhibitor | 0.4176 | 54.5088 | 25 | Complete curve; partial efficacy | -6.3792 | 3.9295 | 0.9982 | -54.1219 | 0.3869 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -54.642 | 0 | 0 | 0 | 0 | 0 | 0 | -40.1122 | -52.6077 | -53.3489 | -56.1314 | -54.642 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 0.7427 | 56.8803 | 25 | Complete curve; partial efficacy | -6.1292 | 1.6266 | 0.9911 | -55.5683 | 1.3121 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -59.709 | 0 | 0.5138 | 0 | 2.1704 | 0 | 0 | -22.5987 | -45.1616 | -50.258 | -52.6911 | -59.709 | QC'd by Prestwick |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 2.5119 | 89.963 | 85 | Complete curve; high efficacy | -5.6 | 2.4064 | 0.9988 | -81.963 | 8 | -1.1 | 0 0 0 0 | -81.0256 | 4.3424 | -26.1944 | -82.8623 | -81.0256 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 3.1623 | 94.5377 | 85 | Complete curve; high efficacy | -5.5 | 4.5045 | 0.9999 | -94.3225 | 0.2153 | -1.1 | 0 0 0 0 | -94.7013 | -0.2373 | -13.1526 | -93.6408 | -94.7013 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 94.817 | 85 | Complete curve; high efficacy | -5.55 | 2.0479 | 0.9999 | -95.8221 | -1.005 | -1.1 | 0 0 0 0 | -95.0616 | -6.2542 | -35.3146 | -94.5292 | -95.0616 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 2.8184 | 90.5207 | 85 | Complete curve; high efficacy | -5.55 | 3.0654 | 0.9989 | -88.5207 | 2 | -1.1 | 0 0 0 0 | -86.8835 | 0 | -24.056 | -89.9601 | -86.8835 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 5.6234 | 96.9742 | 84 | Complete curve; high efficacy | -5.25 | 4.095 | 1 | -95.4742 | 1.5 | -1.1 | 0 0 0 0 | -95.8576 | 1.6559 | 0 | -94.7507 | -95.8576 | QC'd by SynKinase | |||||||||||||||||||||
| Cytotoxic | 3.9811 | 96.1006 | 84 | Complete curve; high efficacy | -5.4 | 4.5045 | 1 | -95.1006 | 1 | -1.1 | 0 0 0 0 | -94.9108 | 0.5692 | -4.2795 | -94.8159 | -94.9108 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 2.5119 | 77.6563 | 84 | Complete curve; high efficacy | -5.6 | 2.0479 | 0.9997 | -80.7421 | -3.0858 | -1.1 | 0 0 0 0 | -80.0369 | -5.0715 | -39.0219 | -77.613 | -80.0369 | QC'd by Microsource | |||||||||||||||||||||
| Cytotoxic | 7.9433 | 99.4986 | 83 | Complete curve; high efficacy | -5.1 | 4.9549 | 0.9997 | -96.9986 | 2.5 | -1.1 | 0 0 0 0 | -96.805 | 1.2306 | 3.5418 | -95.9316 | -96.805 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.8358 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 0.9993 | -95.8358 | 2 | -1.1 | 0 0 0 0 | -95.6445 | 0 | 3.4249 | -95.1788 | -95.6445 | QC'd by Tocris | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 97.3751 | 83 | Complete curve; high efficacy | -5.15 | 4.095 | 1 | -97.3751 | 0 | -1.1 | 0 0 0 0 | -97.1807 | 0 | -0.6843 | -95.5282 | -97.1807 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 102.4399 | 83 | Complete curve; high efficacy | -5.15 | 1.6924 | 0.9998 | -100.4399 | 2 | -1.1 | 0 0 0 0 | -96.7629 | 0 | -9.8984 | -85.0051 | -96.7629 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 96.3568 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -96.3568 | 0 | -1.1 | 0 0 0 0 | -96.1644 | 0 | 0 | -95.5939 | -96.1644 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 7.0795 | 93.6127 | 83 | Complete curve; high efficacy | -5.15 | 4.9549 | 1 | -93.6127 | 0 | -1.1 | 0 0 0 0 | -93.4258 | 0 | 0 | -92.8807 | -93.4258 | QC'd by MedChem Express | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 97.1357 | 83 | Complete curve; high efficacy | -5.05 | 4.9549 | 1 | -97.1357 | 0 | -1.1 | 0 0 0 0 | -96.9418 | 0 | 0 | -94.9322 | -96.9418 | QC'd by APExBIO | |||||||||||||||||||||
| Cytotoxic | 8.9125 | 105.034 | 83 | Complete curve; high efficacy | -5.05 | 1.6436 | 0.9999 | -100.034 | 5 | -1.1 | 0 0 0 0 | -94.7292 | 3.0536 | -3.9173 | -76.9038 | -94.7292 | QC'd by Glixx | |||||||||||||||||||||
| Cytotoxic | 10 | 91.3037 | 82 | Complete curve; high efficacy | -5 | 2.1876 | 1 | -85.8037 | 5.5 | -1.1 | 0 0 0 0 | -84.1212 | 4.8646 | 2.5388 | -67.7158 | -84.1212 | QC'd by SIGMA | |||||||||||||||||||||
| Cytotoxic | 10 | 98.1252 | 82 | Complete curve; high efficacy | -5 | 2.8473 | 0.9999 | -97.6252 | 0.5 | -1.1 | 0 0 0 0 | -96.8504 | 0 | 0 | -83.9555 | -96.8504 | QC'd by Cayman | |||||||||||||||||||||
| Cytotoxic | 11.2202 | 93.8772 | 82 | Complete curve; high efficacy | -4.95 | 2.4064 | 0.9998 | -92.8772 | 1 | -1.1 | 0 0 0 0 | -91.0561 | 0 | 0 | -72.1776 | -91.0561 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.8913 | 60.2348 | 67 | Complete curve; partial efficacy | -6.05 | 3.5117 | 0.9985 | -93.1767 | -32.9418 | -1.2 | 0 0 0 0 | -93.5509 | -51.1212 | -90.8041 | -91.9137 | -93.5509 | QC'd by Selleck | |||||||||||||||||||||
| Cytotoxic | 0.7943 | 56.6802 | 67 | Complete curve; partial efficacy | -6.1 | 3.9295 | 0.9999 | -91.2497 | -34.5695 | -1.2 | 0 0 0 0 | -91.0675 | -40.2642 | -90.3425 | -90.8279 | -91.0675 | QC'd by MedChem Express |
| Phenotype | Potency | Efficacy | Analysis Comment | Abcb4-Activity_Score | Abcb4-Curve_Description | Abcb4-Fit_LogAC50 | Abcb4-Fit_HillSlope | Abcb4-Fit_R2 | Abcb4-Fit_InfiniteActivity | Abcb4-Fit_ZeroActivity | Abcb4-Fit_CurveClass | Abcb4-Excluded_Points | Abcb4-Max_Response | Abcb4-Activity at 0.0001672135 uM | Abcb4-Activity at 0.0002575382 uM | Abcb4-Activity at 0.0005016404 uM | Abcb4-Activity at 0.0007801051 uM | Abcb4-Activity at 0.00152 uM | Abcb4-Activity at 0.00234 uM | Abcb4-Activity at 0.00456 uM | Abcb4-Activity at 0.00702 uM | Abcb4-Activity at 0.014 uM | Abcb4-Activity at 0.021 uM | Abcb4-Activity at 0.041 uM | Abcb4-Activity at 0.063 uM | Abcb4-Activity at 0.123 uM | Abcb4-Activity at 0.190 uM | Abcb4-Activity at 0.332 uM | Abcb4-Activity at 0.562 uM | Abcb4-Activity at 0.995 uM | Abcb4-Activity at 1.687 uM | Abcb4-Activity at 2.986 uM | Abcb4-Activity at 5.062 uM | Abcb4-Activity at 8.957 uM | Abcb4-Activity at 15.19 uM | Abcb4-Activity at 30.72 uM | Abcb4-Activity at 46.08 uM | Abcb4-Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 1.8655 | 83.6781 | 85 | Complete curve; high efficacy | -5.7292 | 2.1211 | 0.9958 | -81.1412 | 2.5369 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -84.5221 | 4.7394 | 0.0711 | 0.7347 | 0 | 4.203 | 2.5617 | 0 | -36.156 | -69.9841 | -79.3391 | -84.5221 | QC'd by JohnsHopkins | |||||||||||||||
| Inhibitor | 2.9566 | 91.2111 | 85 | Complete curve; high efficacy | -5.5292 | 4.095 | 0.9986 | -89.7152 | 1.4959 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.6214 | 0 | 3.1845 | 2.3751 | 4.4192 | 0 | 0 | 0 | -6.7701 | -79.8402 | -90.1247 | -90.6214 | QC'd by BIOMOL | |||||||||||||||
| Inhibitor | 0.5258 | 75.7533 | 66 | Complete curve; partial efficacy | -6.2792 | 1.6436 | 0.9812 | -72.9207 | 2.8326 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -83.2507 | 1.6164 | 2.6238 | 0.4968 | 0.1648 | 3.4229 | -3.4389 | -41.3403 | -59.2172 | -65.1792 | -70.2781 | -83.2507 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 0.4176 | 69.7901 | 66 | Complete curve; partial efficacy | -6.3792 | 1.4781 | 0.9797 | -68.7413 | 1.0487 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -66.2819 | 0 | 0 | 0 | 3.9188 | 0 | -21.5262 | -34.1364 | -68.9433 | -70.5938 | -64.6521 | -66.2819 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 4.1763 | 76.1646 | 63 | Complete curve; partial efficacy | -5.3792 | 3.5117 | 0.9925 | -75.5552 | 0.6094 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -81.4267 | 2.4797 | -0.6495 | 0 | 0.4093 | 0 | 0 | 0 | 0.2759 | -49.4419 | -69.5672 | -81.4267 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 13.2067 | 93.3019 | 42 | Partial curve; high efficacy | -4.8792 | 3.1925 | 0.9975 | -91.742 | 1.5599 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -89.9431 | 0 | 0 | 0.7578 | 4.08 | 2.3903 | 4.4578 | 0 | 2.0927 | -3.2237 | -56.5544 | -89.9431 | QC'd by FLUKA | |||||||||||||||
| Inhibitor | 19.1438 | 88.9975 | 41 | Partial curve; partial efficacy | -4.718 | 1.2221 | 0.9933 | -87.4528 | 1.5448 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -75.7218 | 3.8305 | 2.4299 | 0 | 0 | 0.3691 | 0 | 0 | -11.8159 | -22.6266 | -57.6673 | -75.7218 | QC'd by Tocris | |||||||||||||||
| Inhibitor | 13.2067 | 67.9143 | 41 | Partial curve; partial efficacy | -4.8792 | 3.99 | 0.9993 | -67.7322 | 0.1822 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -66.8816 | 1.2968 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -44.4548 | -66.8816 | QC'd by ChemieTek | |||||||||||||||
| Inhibitor | 20.9312 | 101.2361 | 41 | Partial curve; high efficacy | -4.6792 | 1.21 | 0.8636 | -109.7086 | -8.4724 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.4238 | -16.3994 | -6.9426 | -5.7585 | -2.3855 | 3.3006 | -4.2364 | -16.0867 | -28.2888 | -28.7532 | -32.931 | -91.4238 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 38.197 | 67.0442 | 40 | Partial curve; partial efficacy | -4.418 | 3.132 | 0.9769 | -66.3749 | 0.6693 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -69.1405 | -1.2459 | -3.215 | 0.0103 | 0 | 2.5709 | 0 | 0 | 4.1663 | -0.6063 | -17.2717 | -69.1405 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 0.1177 | 44.8067 | 25 | Complete curve; partial efficacy | -6.9292 | 4.4495 | 0.9752 | -42.4328 | 2.3739 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -48.4636 | 2.486 | 0 | 1.3479 | 4.0586 | 0.2178 | -37.4672 | -35.7594 | -37.7996 | -46.5403 | -43.888 | -48.4636 | QC'd by Prestwick | |||||||||||||||
| Inhibitor | 3.7221 | 71.1376 | 23 | Partial curve; partial efficacy | -5.4292 | 0.8 | 0.9906 | -69.517 | 1.6206 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -62.5142 | 0 | 0.838 | 0 | 0 | 0 | 1.2799 | -13.6984 | -24.464 | -38.7371 | -49.9262 | -62.5142 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 0.7427 | 35.4113 | 23 | Complete curve; partial efficacy | -6.1292 | 1.331 | 0.9735 | -34.0009 | 1.4104 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -37.2815 | 0 | 4.5113 | 0 | 0 | 0 | 0.1616 | -16.9095 | -24.8616 | -29.0497 | -31.0051 | -37.2815 | QC'd by Bio Vision | |||||||||||||||
| Inhibitor | 4.1763 | 36.0646 | 22 | Complete curve; partial efficacy | -5.3792 | 1.5386 | 0.9971 | -35.5646 | 0.5 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -35.708 | 1.0578 | 0 | 0 | 0 | 0.9914 | 0 | 0 | -6.3902 | -20.9174 | -30.078 | -35.708 | QC'd by ChemieTek | |||||||||||||||
| Inhibitor | 4.1763 | 41.2256 | 22 | Partial curve; partial efficacy | -5.3792 | 1.1 | 0.939 | -45.7763 | -4.5507 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -45.2303 | -10.9762 | -10.1428 | -4.3731 | -0.0252 | -1.1837 | -4.6959 | -7.2075 | -17.3549 | -29.1713 | -34.1648 | -45.2303 | QC'd by Glixx | |||||||||||||||
| Inhibitor | 5.8992 | 49.1957 | 22 | Complete curve; partial efficacy | -5.2292 | 1.2876 | 0.9896 | -50.6444 | -1.4487 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -49.6514 | -0.4396 | -0.783 | -2.9902 | -0.8952 | -2.1705 | -4.2059 | -0.5838 | -12.0912 | -23.4657 | -38.4257 | -49.6514 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 7.4267 | 68.7913 | 22 | Complete curve; partial efficacy | -5.1292 | 1 | 0.945 | -76.1718 | -7.3804 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -63.4765 | -4.4203 | -6.308 | -3.6661 | -8.5681 | -8.7544 | -13.4655 | -17.034 | -22.0762 | -25.4423 | -62.6326 | -63.4765 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 3.7221 | 52.7305 | 22 | Complete curve; partial efficacy | -5.4292 | 1.111 | 0.9531 | -49.8878 | 2.8427 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -48.1472 | 3.4889 | 0 | 0 | 0 | 4.9985 | 3.0385 | 4.5308 | -21.0013 | -24.002 | -40.7269 | -48.1472 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 11.7705 | 54.1797 | 21 | Partial curve; partial efficacy | -4.9292 | 1.21 | 0.92 | -55.4151 | -1.2355 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -48.0418 | -9.1728 | -3.027 | -3.9348 | 4.313 | 0.6063 | -1.819 | 3.944 | -3.7766 | -22.0168 | -28.8182 | -48.0418 | QC'd by Selleck | |||||||||||||||
| Inhibitor | 13.2067 | 71.4666 | 21 | Partial curve; partial efficacy | -4.8792 | 1.8079 | 0.996 | -70.3061 | 1.1604 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -63.865 | 2.4384 | 0 | 4.5307 | 0 | 0 | 0.6001 | 0 | 0 | -9.1384 | -39.5919 | -63.865 | QC'd by ChemAxon |
| Phenotype | Potency | Efficacy | Analysis Comment | Abcb5-Activity_Score | Abcb5-Curve_Description | Abcb5-Fit_LogAC50 | Abcb5-Fit_HillSlope | Abcb5-Fit_R2 | Abcb5-Fit_InfiniteActivity | Abcb5-Fit_ZeroActivity | Abcb5-Fit_CurveClass | Abcb5-Excluded_Points | Abcb5-Max_Response | Abcb5-Activity at 0.0001672135 uM | Abcb5-Activity at 0.0002575382 uM | Abcb5-Activity at 0.0005016404 uM | Abcb5-Activity at 0.0007801051 uM | Abcb5-Activity at 0.00152 uM | Abcb5-Activity at 0.00234 uM | Abcb5-Activity at 0.00456 uM | Abcb5-Activity at 0.00702 uM | Abcb5-Activity at 0.014 uM | Abcb5-Activity at 0.021 uM | Abcb5-Activity at 0.041 uM | Abcb5-Activity at 0.063 uM | Abcb5-Activity at 0.123 uM | Abcb5-Activity at 0.190 uM | Abcb5-Activity at 0.332 uM | Abcb5-Activity at 0.562 uM | Abcb5-Activity at 0.995 uM | Abcb5-Activity at 1.687 uM | Abcb5-Activity at 2.986 uM | Abcb5-Activity at 5.062 uM | Abcb5-Activity at 8.957 uM | Abcb5-Activity at 15.19 uM | Abcb5-Activity at 30.72 uM | Abcb5-Activity at 46.08 uM | Abcb5-Activity at 92.17 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.1663 | 93.4793 | 90 | Complete curve; high efficacy | -6.7792 | 3.0654 | 0.9985 | -92.0775 | 1.4018 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -93.7485 | 0 | 1.8336 | 0 | 0 | 0 | -51.892 | -89.1574 | -91.3746 | -92.7835 | -94.1488 | -93.7485 | QC'd by Aobious | |||||||||||||||
| Inhibitor | 0.5899 | 88.7367 | 88 | Complete curve; high efficacy | -6.2292 | 1.6924 | 0.9982 | -87.4669 | 1.2697 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -89.4345 | 2.8682 | 0 | 0.2301 | 0 | 0 | -10.4737 | -40.2184 | -76.7052 | -81.6015 | -87.8627 | -89.4345 | QC'd by ChemieTek | |||||||||||||||
| Inhibitor | 1.177 | 94.296 | 87 | Complete curve; high efficacy | -5.9292 | 4.9549 | 0.9988 | -92.5849 | 1.7111 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -92.2472 | 4.3691 | 3.3888 | 0 | 3.2785 | 0 | 0 | 0 | -78.3275 | -92.3267 | -93.5201 | -92.2472 | QC'd by BIOMOL | |||||||||||||||
| Inhibitor | 0.935 | 83.4465 | 86 | Complete curve; high efficacy | -6.0292 | 4.9549 | 0.964 | -80.917 | 2.5295 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -95.6466 | 0 | 0 | -0.4408 | 3.7187 | 4.0587 | 0 | 3.9436 | -82.4313 | -64.2733 | -77.7031 | -95.6466 | QC'd by FLUKA | |||||||||||||||
| Inhibitor | 1.8655 | 91.8885 | 86 | Complete curve; high efficacy | -5.7292 | 2.7202 | 0.9923 | -92.241 | -0.3525 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.9675 | -7.3716 | -1.7127 | 1.511 | -3.5998 | 2.0798 | -1.3818 | 2.558 | -39.2128 | -90.2281 | -90.7581 | -90.9675 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 2.3485 | 86.6909 | 85 | Complete curve; high efficacy | -5.6292 | 1.4641 | 0.9777 | -84.8191 | 1.8719 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -91.7955 | 0 | 0 | 0.1642 | 0.4773 | 4.4859 | 0 | 0 | -38.3727 | -62.7655 | -70.1641 | -91.7955 | QC'd by Cayman | |||||||||||||||
| Inhibitor | 2.3485 | 82.6481 | 85 | Complete curve; high efficacy | -5.6292 | 1.9673 | 0.9946 | -80.1406 | 2.5075 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -80.5338 | 0 | 0 | 3.6334 | 2.5373 | 0 | 4.3909 | 2.7028 | -28.0682 | -67.1221 | -75.0792 | -80.5338 | QC'd by Aobious | |||||||||||||||
| Inhibitor | 5.8992 | 83.0007 | 83 | Complete curve; high efficacy | -5.2292 | 1.8079 | 0.9905 | -80.7355 | 2.2652 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -80.1328 | 3.7462 | 1.7536 | 0 | 4.5625 | 0 | 0 | 0 | 0 | -38.2042 | -64.673 | -80.1328 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 0.059 | 67.7779 | 69 | Complete curve; partial efficacy | -7.2292 | 3.0654 | 0.9333 | -67.4288 | 0.3491 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -91.3669 | 0.1424 | 0.0449 | -0.4324 | 0 | -39.5866 | -63.8664 | -58.5336 | -65.7629 | -63.6021 | -58.3283 | -91.3669 | QC'd by Chemdiv | |||||||||||||||
| Inhibitor | 0.5899 | 71.2042 | 66 | Complete curve; partial efficacy | -6.2292 | 2.7202 | 0.9933 | -67.4627 | 3.7415 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -70.5516 | 4.6181 | 0 | 3.5838 | 3.5633 | 3.0655 | 2.5098 | -28.5951 | -68.8887 | -63.2607 | -65.0623 | -70.5516 | QC'd by JohnsHopkins | |||||||||||||||
| Inhibitor | 1.8655 | 74.8081 | 65 | Complete curve; partial efficacy | -5.7292 | 1.9282 | 0.9912 | -73.3454 | 1.4626 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -75.8289 | 0 | 4.9182 | 0 | 0.4446 | 0 | 0 | 0 | -36.9146 | -59.514 | -71.5143 | -75.8289 | QC'd by Adooq | |||||||||||||||
| Inhibitor | 2.0931 | 79.9045 | 65 | Complete curve; partial efficacy | -5.6792 | 1.331 | 0.9945 | -78.8108 | 1.0937 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -76.8339 | -2.1416 | 2.0595 | -1.9542 | 2.2288 | 0 | -0.0834 | -6.8816 | -36.5635 | -58.8647 | -71.9734 | -76.8339 | QC'd by APExBIO | |||||||||||||||
| Inhibitor | 1.4818 | 62.2548 | 64 | Complete curve; partial efficacy | -5.8292 | 2.7868 | 0.9796 | -61.0185 | 1.2363 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -70.8526 | 0.0372 | 0 | 1.5519 | 1.7847 | 0 | 0 | 0 | -36.0936 | -54.8403 | -54.7441 | -70.8526 | QC'd by NCGCChem | |||||||||||||||
| Inhibitor | 2.6351 | 81.6528 | 64 | Complete curve; partial efficacy | -5.5792 | 0.7 | 0.9762 | -78.9247 | 2.7281 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -70.3975 | 0 | 0 | 2.3215 | 0 | 0 | 0 | -23.8932 | -36.3847 | -41.8833 | -60.4317 | -70.3975 | QC'd by Prestwick | |||||||||||||||
| Inhibitor | 7.4267 | 73.1508 | 62 | Complete curve; partial efficacy | -5.1292 | 1.6604 | 0.9925 | -71.7169 | 1.4339 | -1.2 | 0 0 0 0 0 0 0 0 0 0 0 | -66.0734 | -1.5 | 0.7198 | 4.5873 | 3.6737 | 0 | 0.1886 | 2.9782 | -6.9791 | -23.1391 | -55.4925 | -66.0734 | QC'd by SynKinase | |||||||||||||||
| Inhibitor | 1.3207 | 104.014 | 46 | Partial curve; high efficacy | -5.8792 | 0.4 | 0.9683 | -92.5426 | 11.4714 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -77.1188 | 3.2785 | 0 | 3.453 | 0 | -5.9269 | -28.1126 | -39.0476 | -38.8783 | -51.1786 | -61.0871 | -77.1188 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 4.1763 | 113.8038 | 45 | Partial curve; high efficacy | -5.3792 | 0.5 | 0.9717 | -108.8438 | 4.96 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -88.4909 | 0.3994 | 0.4511 | 1.1749 | 1.9091 | -3.0363 | -15.2252 | -35.4282 | -37.4575 | -56.0396 | -60.4912 | -88.4909 | QC'd by MedChem Express | |||||||||||||||
| Inhibitor | 11.7705 | 120.0953 | 43 | Partial curve; high efficacy | -4.9292 | 0.7 | 0.989 | -117.4052 | 2.6901 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -88.9433 | -1.2189 | 3.1112 | 4.1556 | 1.4722 | 2.3202 | -1.5136 | -10.9804 | -27.1453 | -40.751 | -58.118 | -88.9433 | QC'd by SIGMA | |||||||||||||||
| Inhibitor | 7.4267 | 95.7015 | 43 | Partial curve; high efficacy | -5.1292 | 1.6604 | 0.9904 | -94.821 | 0.8805 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -87.7972 | -1.3897 | -2.4239 | 0 | 0 | 0 | 3.3978 | 0 | 0 | -35.8834 | -69.5046 | -87.7972 | QC'd by ChemAxon | |||||||||||||||
| Inhibitor | 8.3328 | 95.639 | 43 | Partial curve; high efficacy | -5.0792 | 1.3443 | 0.9859 | -95.3335 | 0.3055 | -2.1 | 0 0 0 0 0 0 0 0 0 0 0 | -84.0684 | 2.8768 | 0 | 1.4012 | 2.2737 | 0 | 0 | -4.1433 | -16.731 | -26.0852 | -71.319 | -84.0684 | QC'd by Selleck |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.00457 uM | Activity at 0.00705 uM | Activity at 0.023 uM | Activity at 0.046 uM | Activity at 0.070 uM | Activity at 0.104 uM | Activity at 0.147 uM | Activity at 0.228 uM | Activity at 0.454 uM | Activity at 0.702 uM | Activity at 0.990 uM | Activity at 1.179 uM | Activity at 2.205 uM | Activity at 3.547 uM | Activity at 5.245 uM | Activity at 6.528 uM | Activity at 11.35 uM | Activity at 18.98 uM | Activity at 27.12 uM | Activity at 37.89 uM | Activity at 57.10 uM | Activity at 85.70 uM | Activity at 114.4 uM | Activity at 171.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.7079 | 34.8288 | 10 | Complete curve; partial efficacy; poor fit | -6.15 | 4.9549 | 0.7525 | -34.8113 | 0.0174 | -1.4 | 0 0 0 0 | -43.6793 | -3.7355 | -37.8905 | -22.6342 | -43.6793 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 35.4813 | 36.7648 | 10 | Single point of activity | -4.45 | 2.4064 | 0.8748 | -40.7648 | -4 | -3 | 0 0 0 0 | -31.8873 | -11.4596 | 0 | -6.0521 | -31.8873 | QC'd by Pharmaron | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.3927 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7948 | -48.5731 | -8.1804 | -3 | 0 0 0 0 | -41.7275 | -5.1127 | -20.8986 | -3.4837 | -41.7275 | QC'd by FLUKA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 36.3021 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9302 | -39.3021 | -3 | -3 | 0 0 0 0 | -33.1684 | -8.7659 | 0 | -0.1246 | -33.1684 | QC'd by Prestwick | |||||||||||||||||||||
| Inhibitor | 10 | 91.8254 | 10 | Partial curve; high efficacy; poor fit | -5 | 3.9295 | 1 | -91.3254 | 0.5 | -2.3 | 1 0 0 0 | -91.1431 | -30.038 | 0 | -57.0259 | -91.1431 | QC'd by APExBIO | |||||||||||||||||||||
| Inhibitor | 39.8107 | 88.8726 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9981 | -87.8726 | 1 | -3 | 0 0 0 0 | -75.3105 | 0 | 0 | 3.3645 | -75.3105 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 39.8107 | 39.074 | 10 | Single point of activity | -4.4 | 4.9549 | 0.9982 | -38.574 | 0.5 | -3 | 0 0 0 0 | -32.9783 | 0 | 0 | 1.4313 | -32.9783 | QC'd by Carbosynth | |||||||||||||||||||||
| Inhibitor | 17.7828 | 45.6593 | 10 | Partial curve; partial efficacy; poor fit | -4.75 | 1.9673 | 0.9887 | -54.3257 | -8.6664 | -2.4 | 0 0 0 0 | -50.2467 | -11.0836 | -6.8054 | -21.6158 | -50.2467 | QC'd by TargetMol | |||||||||||||||||||||
| Inhibitor | 39.8107 | 74.9786 | 10 | Single point of activity | -4.4 | 4.4495 | 0.9815 | -77.9786 | -3 | -3 | 0 0 0 0 | -65.3989 | -8.9317 | 0 | 0 | -65.3989 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 35.788 | 10 | Single point of activity | -4.4 | 4.4495 | 0.945 | -39.8408 | -4.0529 | -3 | 0 0 0 0 | -34.034 | -8.1712 | -5.8755 | -0.0441 | -34.034 | QC'd by Adooq | |||||||||||||||||||||
| Inhibitor | 19.9526 | 98.5475 | 10 | Partial curve; high efficacy; poor fit | -4.7 | 1.9673 | 0.9936 | -101.5475 | -3 | -2.3 | 0 0 0 0 | -90.5058 | -6.6702 | 0 | -28.4282 | -90.5058 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 39.8107 | 94.2096 | 10 | Partial curve; high efficacy; poor fit | -4.4 | 4.4495 | 0.9731 | -106.3898 | -12.1802 | -2.3 | 0 0 0 0 | -90.4675 | -6.8168 | -21.693 | -10.2877 | -90.4675 | QC'd by Axon Medchem | |||||||||||||||||||||
| Inhibitor | 39.8107 | 68.3394 | 10 | Single point of activity | -4.4 | 4.9549 | 0.8933 | -61.3394 | 7 | -3 | 0 0 0 0 | -51.5329 | 0 | 0 | 21.3412 | -51.5329 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 11.2202 | 45.0575 | 10 | Partial curve; partial efficacy; poor fit | -4.95 | 1.8579 | 0.9996 | -42.5575 | 2.5 | -2.4 | 1 0 0 0 | -40.794 | -21.6798 | 0 | -20.0057 | -40.794 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 22.3872 | 113.3323 | 10 | Partial curve; high efficacy; poor fit | -4.65 | 1.6924 | 1 | -111.3323 | 2 | -2.3 | 1 0 0 0 | -91.8583 | -33.8793 | 0 | -25.3979 | -91.8583 | QC'd by Microsource | |||||||||||||||||||||
| Inhibitor | 7.0795 | 44.42 | 10 | Single point of activity | -5.15 | 4.9549 | 0.6152 | -48.42 | -4 | -3 | 0 0 0 0 | -44.8333 | -14.7954 | -20.376 | 0 | -44.8333 | QC'd by SIGMA | |||||||||||||||||||||
| Inhibitor | 39.8107 | 32.9185 | 10 | Single point of activity | -4.4 | 4.9549 | 0.6127 | -36.9185 | -4 | -3 | 0 0 0 0 | -32.0154 | 2.7163 | -20.0828 | 0 | -32.0154 | QC'd by Selleck | |||||||||||||||||||||
| Inhibitor | 39.8107 | 51.1844 | 10 | Single point of activity | -4.4 | 4.4495 | 1 | -51.1844 | 0 | -3 | 0 0 0 0 | -42.6537 | 0 | 0 | 0 | -42.6537 | QC'd by MedChem Express | |||||||||||||||||||||
| Inhibitor | 10 | 58.1799 | 10 | Partial curve; partial efficacy; poor fit | -5 | 3.5117 | 0.9887 | -59.1799 | -1 | -2.4 | 0 0 0 0 | -59.8069 | -4.8747 | 2.0564 | -35.7833 | -59.8069 | QC'd by DC Chemicals | |||||||||||||||||||||
| Inhibitor | 39.8107 | 40.2901 | 10 | Single point of activity | -4.4 | 4.4495 | 0.7334 | -45.6865 | -5.3964 | -3 | 0 0 0 0 | -38.9054 | -16.4277 | -13.0282 | -1.1636 | -38.9054 | QC'd by Adooq |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000386857 uM | Activity at 0.0001060182 uM | Activity at 0.0002019424 uM | Activity at 0.0004510146 uM | Activity at 0.0009668607 uM | Activity at 0.00168 uM | Activity at 0.00290 uM | Activity at 0.00509 uM | Activity at 0.00877 uM | Activity at 0.025 uM | Activity at 0.041 uM | Activity at 0.083 uM | Activity at 0.136 uM | Activity at 0.247 uM | Activity at 0.490 uM | Activity at 1.070 uM | Activity at 2.238 uM | Activity at 4.221 uM | Activity at 6.448 uM | Activity at 12.37 uM | Activity at 30.23 uM | Activity at 57.68 uM | Activity at 114.0 uM | Activity at 227.8 uM | Activity at 383.5 uM | Activity at 573.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 3.7924 | 3.15 | 0.963 | 2.3829 | 3.4088 | 3.7221 | 3.7924 | QC'd by MedChem Express | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.2789 | 3.5102 | 1.528 | 1.9238 | 4.6346 | 6.4182 | 1.2789 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.0037 | -4.4248 | -0.615 | -1.2841 | -0.0588 | -4.0514 | 0.0037 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.0131 | -5.3427 | -2.388 | -5.1553 | -1.5524 | -1.7506 | -3.0131 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.373 | 0.8235 | 0.0316 | 2.107 | 1.7002 | -1.9138 | 3.373 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.2123 | -4.9482 | 0.0182 | 2.4902 | -0.0466 | 3.4729 | 2.2123 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -6.8722 | -2.3397 | -1.6401 | -4.488 | -0.7912 | -2.054 | -6.8722 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6887 | 2.9795 | 4.8757 | 2.0264 | 2.2902 | 4.458 | 2.6887 | QC'd by MedChem Express | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -3.8031 | -1.1794 | -1.5257 | -1.5947 | 1.0625 | -2.7807 | -3.8031 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -10.2079 | -6.2462 | -2.2383 | -3.1976 | -2.6796 | -7.2482 | -10.2079 | QC'd by Selleck | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.2044 | 1.1558 | 1.2797 | 1.8267 | -0.4088 | 0.0627 | 3.2044 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -8.9309 | -1.3351 | -3.9232 | -1.9433 | -5.1495 | -5.1305 | -8.9309 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.583 | -2.8916 | -5.1264 | -4.8462 | -1.1066 | 0.1205 | -2.583 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.7511 | 0.2404 | -3.0231 | -3.8049 | -6.4833 | 1.0107 | -2.7511 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.502 | 1.0269 | 0.0012 | 1.2652 | 0.3956 | 0.7999 | -4.502 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.2916 | 1.5967 | 1.7255 | 4.1293 | 0.6629 | 1.259 | 2.2916 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.0438 | -1.4768 | -0.4907 | 0.2776 | 2.287 | -0.8523 | 3.0438 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -4.3119 | -0.9159 | -1.5721 | -0.7878 | 0.5085 | -2.4781 | -4.3119 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.058 | 5.2803 | 5.2865 | 7.8954 | 10.1632 | 4.5574 | 1.058 | QC'd by Analyticon | ||||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.9292 | -2.6967 | -2.5902 | -0.5082 | 2.8487 | 4.351 | 2.9292 | QC'd by Analyticon |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 0.6 | Kd | = | 600 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 1.5 | Kd | = | 1500 | nM |
| 2.8 | Kd | = | 2800 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 1.6 | Kd | = | 1600 | nM |
| 0.21 | Kd | = | 210 | nM |
| 0.086 | Kd | = | 86 | nM |
| 0.0044 | Kd | = | 4.4 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.071 | Kd | = | 71 | nM |
| 0.026 | Kd | = | 26 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.25 | Kd | = | 250 | nM |
| 5.7 | Kd | = | 5700 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 4.5 | Kd | = | 4500 | nM |
| 2.2 | Kd | = | 2200 | nM |
| 0.39 | Kd | = | 390 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.34 | Kd | = | 340 | nM |
| 0.44 | Kd | = | 440 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 2.9 | Kd | = | 2900 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 1 | Kd | = | 1000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.5 | Kd | = | 500 | nM |
| 1.5 | Kd | = | 1500 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| Rep1PKANHIBITKGP-Outcome | Rep1PKANHIBITKGP-Phenotype | Rep1PKANHIBITKGP-Potency | Rep1PKANHIBITKGP-Efficacy | Rep1PKANHIBITKGP-Analysis Comment | Rep1PKANHIBITKGP-Activity_Score | Rep1PKANHIBITKGP-Curve_Description | Rep1PKANHIBITKGP-Fit_LogAC50 | Rep1PKANHIBITKGP-Fit_HillSlope | Rep1PKANHIBITKGP-Fit_R2 | Rep1PKANHIBITKGP-Fit_InfiniteActivity | Rep1PKANHIBITKGP-Fit_ZeroActivity | Rep1PKANHIBITKGP-Fit_CurveClass | Rep1PKANHIBITKGP-Excluded_Points | Rep1PKANHIBITKGP-Max_Response | Rep1PKANHIBITKGP-Activity at 0.0000973841 uM | Rep1PKANHIBITKGP-Activity at 0.0002921522 uM | Rep1PKANHIBITKGP-Activity at 0.0005695054 uM | Rep1PKANHIBITKGP-Activity at 0.0009722003 uM | Rep1PKANHIBITKGP-Activity at 0.00172 uM | Rep1PKANHIBITKGP-Activity at 0.00292 uM | Rep1PKANHIBITKGP-Activity at 0.00438 uM | Rep1PKANHIBITKGP-Activity at 0.00872 uM | Rep1PKANHIBITKGP-Activity at 0.013 uM | Rep1PKANHIBITKGP-Activity at 0.026 uM | Rep1PKANHIBITKGP-Activity at 0.044 uM | Rep1PKANHIBITKGP-Activity at 0.079 uM | Rep1PKANHIBITKGP-Activity at 0.116 uM | Rep1PKANHIBITKGP-Activity at 0.236 uM | Rep1PKANHIBITKGP-Activity at 0.384 uM | Rep1PKANHIBITKGP-Activity at 0.707 uM | Rep1PKANHIBITKGP-Activity at 1.006 uM | Rep1PKANHIBITKGP-Activity at 2.120 uM | Rep1PKANHIBITKGP-Activity at 3.323 uM | Rep1PKANHIBITKGP-Activity at 6.367 uM | Rep1PKANHIBITKGP-Activity at 8.708 uM | Rep1PKANHIBITKGP-Activity at 19.09 uM | Rep1PKANHIBITKGP-Activity at 28.75 uM | Rep1PKANHIBITKGP-Activity at 46.00 uM | Rep1PKANHIBITKGP-Activity at 57.50 uM | Rep2PKANHIBITKGP-Outcome | Rep2PKANHIBITKGP-Phenotype | Rep2PKANHIBITKGP-Potency | Rep2PKANHIBITKGP-Efficacy | Rep2PKANHIBITKGP-Analysis Comment | Rep2PKANHIBITKGP-Activity_Score | Rep2PKANHIBITKGP-Curve_Description | Rep2PKANHIBITKGP-Fit_LogAC50 | Rep2PKANHIBITKGP-Fit_HillSlope | Rep2PKANHIBITKGP-Fit_R2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Inhibitor | 0.1933 | 95.4938 | 90 | Complete curve; high efficacy | -6.7138 | 1.6259 | 0.9826 | -92.4938 | 3 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -90.553 | 9.1716 | 7.0489 | 0.6645 | -13.8776 | -7.0369 | -58.5418 | -78.7359 | -90.9298 | -92.9508 | -93.4281 | -90.553 | 2 | Inhibitor | 0.1933 | 98.969 | 90 | Complete curve; high efficacy | -6.7138 | 3.0654 | 0.9933 | ||||||||||||||||
| 3 | Inhibitor | 21.6863 | 60.2092 | 20 | Partial curve; partial efficacy | -4.6638 | 2.4064 | 0.951 | -56.7092 | 3.5 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -52.5085 | 9.1625 | 5.0068 | 6.6027 | 4.3208 | 7.0361 | -1.946 | -1.0166 | -3.2899 | 0.0286 | -19.9227 | -52.5085 | 3 | Inhibitor | 24.3324 | 60.6298 | 20 | Partial curve; partial efficacy | -4.6138 | 2.2526 | 0.8837 | ||||||||||||||||
| 1 | Inactive | 0.0019 | 14.6466 | 0 | -8.7138 | 2.8473 | 0.6002 | -3.6466 | 11 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 7.7903 | 9.1847 | -0.1642 | -4.063 | -0.4829 | -7.2777 | -10.5388 | -1.1777 | -0.4399 | -0.9527 | -2.3716 | 7.7903 | 1 | Inactive | 0.1535 | 17.3315 | 0 | -6.8138 | 0.2 | 0.4095 | ||||||||||||||||||
| 1 | Inactive | 8.413 | 30.9999 | 0 | -5.0751 | 1.6436 | 0.7141 | -28.4999 | 2.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -25.4166 | 9.1162 | 8.0349 | 7.6562 | 6.3696 | -8.7701 | -3.9343 | -4.3898 | 4.9596 | -3.4173 | -14.3932 | -25.4166 | 3 | Inhibitor | 13.3337 | 36.0417 | 10 | Partial curve; partial efficacy; poor fit | -4.8751 | 3.2975 | 0.8462 | |||||||||||||||||
| 1 | Inactive | 3.0633 | 29.4952 | 0 | -5.5138 | 3.5117 | 0.5749 | -30.4952 | -1 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | -27.496 | 8.5684 | 7.6751 | -12.229 | -10.1998 | -7.3363 | -2.8307 | 0.0253 | 5.1929 | 2.1315 | -6.0187 | -27.496 | 3 | Inhibitor | 2.7301 | 41.0739 | 10 | Single point of activity | -5.5638 | 3.0654 | 0.7473 | |||||||||||||||||
| 3 | Inhibitor | 0.0137 | 21.3659 | 10 | Complete curve; partial efficacy; poor fit | -7.8638 | 0.3 | 0.8001 | -8.3659 | 13 | -1.4 | 0 0 0 0 0 0 0 0 0 0 1 | 9.143 | 9.2206 | 3.5597 | -1.2858 | 1.3846 | -0.6214 | -0.3245 | -1.2325 | -2.8422 | -6.9167 | -7.8049 | 9.143 | 1 | Inactive | 0.0344 | 14.7963 | 0 | -7.4638 | 0.8 | 0.7397 | |||||||||||||||||
| 1 | Inactive | 0.0061 | 16.4356 | 0 | -8.2138 | 3.5117 | 0.6941 | -6.9356 | 9.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 5.946 | 9.2101 | 8.3102 | -3.9398 | -5.7458 | -4.0508 | -5.5132 | -12.782 | -3.5255 | -1.1495 | -15.7797 | 5.946 | 1 | Inactive | 0.0217 | 11.1956 | 0 | -7.6638 | 3.0654 | 0.9513 | ||||||||||||||||||
| 3 | Inhibitor | 12.1951 | 38.405 | 10 | Single point of activity | -4.9138 | 4.095 | 0.7727 | -39.405 | -1 | -3 | 0 0 0 0 0 0 0 0 0 0 1 | 8.7812 | 9.1444 | -11.4392 | -4.6715 | -3.1109 | -2.6352 | -2.5532 | -0.4698 | 6.068 | -3.5854 | -34.2235 | 8.7812 | 1 | Inactive | 0.1535 | 11.6118 | 0 | -6.8138 | 1.4487 | 0.4916 | |||||||||||||||||
| 3 | Inhibitor | 0.0069 | 21.1183 | 10 | Complete curve; partial efficacy; poor fit | -8.1638 | 1.1 | 0.8374 | -9.1183 | 12 | -1.4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.7499 | 9.2061 | 8.3184 | -3.2942 | -2.428 | -7.223 | -12.1056 | -5.0767 | -4.8859 | -13.0153 | -10.7877 | 8.7499 | 1 | Inactive | 0.0039 | 11.8205 | 0 | -8.4138 | 4.9549 | 0.4004 | |||||||||||||||||
| 3 | Inhibitor | 0.0077 | 23.1547 | 10 | Complete curve; partial efficacy; poor fit | -8.1138 | 1 | 0.9003 | -10.6547 | 12.5 | -1.4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.5068 | 9.1336 | 7.9954 | -0.9323 | -5.9609 | -9.4328 | -6.2172 | -9.3564 | -11.3544 | -8.199 | -16.3789 | 8.5068 | 1 | Inactive | 0 | 0 | |||||||||||||||||||||
| 1 | Inactive | 0.0061 | 14.4876 | 0 | -8.2138 | 3.1925 | 0.511 | -5.4876 | 9 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.5908 | 8.9797 | 8.0977 | -1.7008 | -6.7555 | -0.9011 | -8.7915 | -12.073 | -9.2175 | 8.2946 | -9.4064 | 8.5908 | 1 | Inactive | 12.1951 | 24.403 | 0 | -4.9138 | 0.6 | 0.6827 | ||||||||||||||||||
| 1 | Inactive | 0.0043 | 13.6358 | 0 | -8.3638 | 4.9549 | 0.4054 | -4.1358 | 9.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 7.6997 | 9.1697 | 8.2572 | -8.1789 | -11.7798 | 7.6871 | -11.1599 | -6.0337 | -6.26 | -2.3213 | 5.7955 | 7.6997 | 1 | Inactive | 0.0049 | 13.8095 | 0 | -8.3138 | 4.9549 | 0.5067 | ||||||||||||||||||
| 1 | Inactive | 0.0069 | 11.7993 | 0 | -8.1638 | 2.7202 | 0.548 | -2.2993 | 9.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 7.9011 | 9.0898 | 8.4612 | 2.0427 | -2.7135 | -3.5496 | -4.9281 | -6.4994 | -5.2834 | 8.1698 | 0.4167 | 7.9011 | 1 | Inactive | 0 | 0 | ||||||||||||||||||||||
| 1 | Inactive | 0.1087 | 15.7879 | 0 | -6.9638 | 4.9549 | 0.9713 | -7.2879 | 8.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.1278 | 8.8866 | 7.8175 | 8.2653 | 7.7959 | 6.3049 | -9.8233 | -4.8282 | -6.5981 | -6.7716 | -7.7551 | 8.1278 | 1 | Inactive | 0.0122 | 13.2837 | 0 | -7.9138 | 4.9549 | 0.5736 | ||||||||||||||||||
| 1 | Inactive | 6.8578 | 11.3055 | 0 | -5.1638 | 3.9295 | 0.5301 | -5.8055 | 5.5 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 6.3955 | 9.2232 | 6.7836 | 8.2572 | 0.5279 | 8.0037 | -1.2896 | 4.379 | 6.7558 | 0.9866 | -5.6712 | 6.3955 | 1 | Inactive | 0.0039 | 11.5307 | 0 | -8.4138 | 4.9549 | 0.3539 | ||||||||||||||||||
| 1 | Inactive | 0.3437 | 13.2841 | 0 | -6.4638 | 4.9549 | 0.707 | -9.2841 | 4 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.9977 | 9.1904 | -0.3005 | -2.0482 | 2.9588 | 8.5277 | 3.8254 | -13.1534 | -12.299 | -7.6023 | -3.9551 | 8.9977 | 1 | Inactive | 0.0039 | 23.6167 | 0 | -8.4138 | 4.9549 | 0.5004 | ||||||||||||||||||
| 1 | Inactive | 0.0012 | 15.9464 | 0 | -8.9138 | 4.9549 | 0.7117 | -2.9464 | 13 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | 8.9581 | 9.2492 | -4.7024 | -5.0797 | 0.582 | 0.6638 | -7.0386 | -2.0883 | -3.0491 | -4.2844 | -1.7833 | 8.9581 | 1 | Inactive | 0 | 0 | ||||||||||||||||||||||
| 1 | Inactive | 0 | 0 | 0 | 0 | 4 | 7.5453 | 9.1777 | -5.7671 | 4.4788 | 6.5871 | 1.399 | 1.3441 | 0.8166 | -3.1166 | -0.0265 | -0.705 | 7.5453 | 1 | Inactive | 0.0049 | 12.5818 | 0 | -8.3138 | 4.9549 | 0.9081 | |||||||||||||||||||||||
| 1 | Inactive | 0 | 0 | 0 | 0 | 4 | 8.7214 | 8.806 | 4.4672 | 7.7734 | -18.0008 | 7.9606 | -3.7599 | -3.9841 | 3.4359 | 8.2533 | -10.2032 | 8.7214 | 1 | Inactive | 0 | 0 | |||||||||||||||||||||||||||
| 1 | Inactive | 0.0386 | 21.4442 | 0 | -7.4138 | 1.7529 | 0.8706 | -11.9442 | 9.5 | 4 | 0 1 0 0 0 0 0 0 0 0 1 | 8.9302 | 9.2816 | -26.8519 | 8.6347 | 1.7444 | -5.6961 | -13.7557 | -15.0327 | -9.7063 | -4.8836 | -17.0368 | 8.9302 | 1 | Inactive | 3.0633 | 11.471 | 0 | -5.5138 | 4.9549 | 0.658 |
| Rep1PKANHIBITSDR-Outcome | Rep1PKANHIBITSDR-Phenotype | Rep1PKANHIBITSDR-Potency | Rep1PKANHIBITSDR-Efficacy | Rep1PKANHIBITSDR-Analysis Comment | Rep1PKANHIBITSDR-Activity_Score | Rep1PKANHIBITSDR-Curve_Description | Rep1PKANHIBITSDR-Fit_LogAC50 | Rep1PKANHIBITSDR-Fit_HillSlope | Rep1PKANHIBITSDR-Fit_R2 | Rep1PKANHIBITSDR-Fit_InfiniteActivity | Rep1PKANHIBITSDR-Fit_ZeroActivity | Rep1PKANHIBITSDR-Fit_CurveClass | Rep1PKANHIBITSDR-Excluded_Points | Rep1PKANHIBITSDR-Max_Response | Rep1PKANHIBITSDR-Activity at 0.0000556526 uM | Rep1PKANHIBITSDR-Activity at 0.0001669578 uM | Rep1PKANHIBITSDR-Activity at 0.0003254584 uM | Rep1PKANHIBITSDR-Activity at 0.0005555887 uM | Rep1PKANHIBITSDR-Activity at 0.0009829345 uM | Rep1PKANHIBITSDR-Activity at 0.00167 uM | Rep1PKANHIBITSDR-Activity at 0.00250 uM | Rep1PKANHIBITSDR-Activity at 0.00498 uM | Rep1PKANHIBITSDR-Activity at 0.00768 uM | Rep1PKANHIBITSDR-Activity at 0.015 uM | Rep1PKANHIBITSDR-Activity at 0.025 uM | Rep1PKANHIBITSDR-Activity at 0.045 uM | Rep1PKANHIBITSDR-Activity at 0.066 uM | Rep1PKANHIBITSDR-Activity at 0.135 uM | Rep1PKANHIBITSDR-Activity at 0.219 uM | Rep1PKANHIBITSDR-Activity at 0.404 uM | Rep1PKANHIBITSDR-Activity at 0.575 uM | Rep1PKANHIBITSDR-Activity at 1.211 uM | Rep1PKANHIBITSDR-Activity at 1.899 uM | Rep1PKANHIBITSDR-Activity at 3.639 uM | Rep1PKANHIBITSDR-Activity at 4.976 uM | Rep1PKANHIBITSDR-Activity at 10.91 uM | Rep1PKANHIBITSDR-Activity at 16.43 uM | Rep1PKANHIBITSDR-Activity at 26.29 uM | Rep1PKANHIBITSDR-Activity at 32.86 uM | Rep3PKANHIBITSDR-Outcome | Rep3PKANHIBITSDR-Phenotype | Rep3PKANHIBITSDR-Potency | Rep3PKANHIBITSDR-Efficacy | Rep3PKANHIBITSDR-Analysis Comment | Rep3PKANHIBITSDR-Activity_Score | Rep3PKANHIBITSDR-Curve_Description | Rep3PKANHIBITSDR-Fit_LogAC50 | Rep3PKANHIBITSDR-Fit_HillSlope | Rep3PKANHIBITSDR-Fit_R2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | Activator | 9.876 | 38.3028 | 21 | Partial curve; partial efficacy | -5.0054 | 1.21 | 0.9825 | 42.3028 | 4 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 35.1007 | 3.6224 | 4.6609 | 4.5344 | 5.7315 | 3.7738 | 1.3769 | 5.1251 | 9.0738 | 11.411 | 24.5404 | 35.1007 | 3 | Activator | 9.876 | 42.9243 | 21 | Partial curve; partial efficacy | -5.0054 | 1 | 0.993 | ||||||||||||||||
| 3 | Activator | 12.4332 | 32.3314 | 21 | Partial curve; partial efficacy | -4.9054 | 1.3723 | 0.9699 | 39.3314 | 7 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 34.8126 | 5.2735 | 6.3131 | 5.3303 | 5.4255 | 7.1165 | 7.7903 | 8.5848 | 10.0526 | 12.9409 | 19.7153 | 34.8126 | 3 | Activator | 13.9503 | 29.9389 | 10 | Partial curve; partial efficacy; poor fit | -4.8554 | 1.6604 | 0.9044 | ||||||||||||||||
| 3 | Activator | 11.0811 | 39.8055 | 21 | Partial curve; partial efficacy | -4.9554 | 1.6259 | 0.7745 | 42.4781 | 2.6726 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 36.8982 | 6.2382 | 1.7035 | 5.6099 | 6.6743 | 2.1382 | 2.0613 | 5.913 | -12.3562 | 15.2777 | 20.8106 | 36.8982 | 3 | Activator | 9.876 | 47.1861 | 21 | Partial curve; partial efficacy | -5.0054 | 0.8 | 0.9712 | ||||||||||||||||
| 3 | Activator | 3.5041 | 42.8378 | 22 | Complete curve; partial efficacy | -5.4554 | 1 | 0.9859 | 46.3378 | 3.5 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 42.5976 | 6.3288 | 4.5846 | 2.8627 | 4.344 | 2.1643 | 1.8852 | 8.4939 | 16.6439 | 24.7048 | 35.5279 | 42.5976 | 3 | Activator | 2.4807 | 34.4002 | 22 | Complete curve; partial efficacy | -5.6054 | 1 | 0.9928 | ||||||||||||||||
| 3 | Activator | 0.2211 | 58.0252 | 27 | Complete curve; partial efficacy | -6.6554 | 1.4641 | 0.9727 | 66.0252 | 8 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 60.3698 | 5.9949 | 4.4886 | 8.3689 | 11.6148 | 21.1349 | 19.3591 | 52.3781 | 64.528 | 65.5595 | 67.2502 | 60.3698 | 3 | Activator | 0.088 | 51.6141 | 27 | Complete curve; partial efficacy | -7.0554 | 0.9 | 0.9791 | ||||||||||||||||
| 3 | Activator | 12.4332 | 39.1023 | 21 | Partial curve; partial efficacy | -4.9054 | 1.3443 | 0.9724 | 45.6023 | 6.5 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 38.1274 | 6.6354 | 7.7659 | 7.129 | 7.6527 | 3.8934 | 4.3023 | 6.8222 | 11.3074 | 11.6084 | 23.2168 | 38.1274 | 3 | Activator | 12.4332 | 41.5436 | 21 | Partial curve; partial efficacy | -4.9054 | 1.1 | 0.9778 | ||||||||||||||||
| 3 | Activator | 4.4115 | 47.8699 | 22 | Partial curve; partial efficacy | -5.3554 | 1 | 0.9857 | 48.8568 | 0.9869 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 45.6629 | -1.3052 | -1.6776 | 1.3701 | 1.3769 | 3.432 | 4.7728 | 6.5724 | 10.603 | 21.4665 | 33.6187 | 45.6629 | 3 | Activator | 3.5041 | 59.0587 | 23 | Partial curve; partial efficacy | -5.4554 | 0.6 | 0.993 | ||||||||||||||||
| 3 | Activator | 11.0811 | 43.162 | 21 | Partial curve; partial efficacy | -4.9554 | 1.2475 | 0.9901 | 50.162 | 7 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 42.3563 | 5.1005 | 6.0861 | 6.1049 | 6.8856 | 8.5803 | 7.8446 | 8.8421 | 10.3901 | 15.4998 | 27.0142 | 42.3563 | 3 | Activator | 12.4332 | 47.4977 | 21 | Partial curve; partial efficacy | -4.9054 | 1.331 | 0.9772 | ||||||||||||||||
| 3 | Activator | 3.4147 | 23 | 10 | Complete curve; partial efficacy; poor fit | -5.4667 | 1.4641 | 0.9501 | 29.5 | 6.5 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 27.064 | 7.6035 | 8.1208 | 8.9056 | 7.7677 | 3.809 | 3.9051 | 5.9923 | 9.0798 | 12.8024 | 22.1295 | 27.064 | 3 | Activator | 3.8313 | 38.2789 | 22 | Partial curve; partial efficacy | -5.4167 | 1.1 | 0.9848 | ||||||||||||||||
| 3 | Activator | 7.8448 | 43.381 | 21 | Partial curve; partial efficacy | -5.1054 | 0.8 | 0.7863 | 30.5206 | -12.8604 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 22.3128 | -3.5301 | -17.4311 | -18.6337 | -8.3189 | -13.8295 | -16.1973 | -11.4241 | 6.0096 | -5.4225 | 12.4971 | 22.3128 | 3 | Activator | 0.0031 | 33.1306 | 21 | Complete curve; partial efficacy | -8.5054 | 4.5045 | 0.7834 | ||||||||||||||||
| 3 | Activator | 4.4115 | 22 | 10 | Complete curve; partial efficacy; poor fit | -5.3554 | 0.8 | 0.9701 | 30 | 8 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 26.5391 | 8.807 | 7.323 | 6.6387 | 9.6077 | 8.231 | 7.5792 | 12.5435 | 14.2224 | 16.7024 | 22.8006 | 26.5391 | 3 | Activator | 2.7834 | 30 | 10 | Partial curve; partial efficacy; poor fit | -5.5554 | 0.5 | 0.9868 | ||||||||||||||||
| 3 | Activator | 6.9917 | 40.5806 | 21 | Partial curve; partial efficacy | -5.1554 | 0.8 | 0.9698 | 24 | -16.5806 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 17.4034 | -18.7848 | -18.8172 | -18.0618 | -14.0517 | -12.4787 | -14.083 | -14.0191 | -7.5308 | -1.9297 | 6.1451 | 17.4034 | 1 | Inactive | 0.0099 | 16.4205 | 0 | -8.0054 | 4.9549 | 0.7087 | |||||||||||||||||
| 3 | Activator | 3.9317 | 39.7988 | 21 | Complete curve; partial efficacy | -5.4054 | 1.1 | 0.8872 | 28.2367 | -11.5621 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 26.7242 | -6.5666 | -10.1629 | -8.1152 | -13.1379 | -17.1351 | -12.2696 | -13.8723 | 6.4021 | 1.5421 | 19.2899 | 26.7242 | 1 | Inactive | 1.1081 | 44.86 | 0 | -5.9554 | 1.4163 | 0.8173 | |||||||||||||||||
| 3 | Activator | 11.0811 | 40.8211 | 21 | Partial curve; partial efficacy | -4.9554 | 1.1 | 0.9072 | 26 | -14.8211 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 19.5654 | -19.8509 | -14.3868 | -14.0101 | -17.301 | -16.4221 | -6.5724 | -13.7697 | -10.1189 | -5.4667 | 2.3527 | 19.5654 | 1 | Inactive | 7.8448 | 47.6311 | 0 | -5.1054 | 4.9549 | 0.7111 | |||||||||||||||||
| 3 | Activator | 13.9503 | 26.5 | 10 | Partial curve; partial efficacy; poor fit | -4.8554 | 1.1 | 0.9443 | 32 | 5.5 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 25.7656 | 5.4412 | 4.0069 | 3.7564 | 4.3155 | 7.4732 | 7.4392 | 8.4305 | 7.2456 | 10.665 | 15.3898 | 25.7656 | 3 | Activator | 9.876 | 35.6929 | 10 | Partial curve; partial efficacy; poor fit | -5.0054 | 0.9 | 0.9688 | ||||||||||||||||
| 3 | Activator | 0.9876 | 48.5969 | 23 | Complete curve; partial efficacy | -6.0054 | 2.3031 | 0.8893 | 42.9041 | -5.6928 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 43.0963 | -6.448 | 3.7026 | 0.4371 | 3.0688 | -13.1805 | -21.4106 | -0.4668 | 25.653 | 33.7441 | 48.3975 | 43.0963 | 1 | Inactive | 0.7845 | 29.1062 | 0 | -6.1054 | 4.9549 | 0.6928 | |||||||||||||||||
| 1 | Inactive | 13.9503 | 12.5 | 0 | -4.8554 | 1.8265 | 0.8773 | 18 | 5.5 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 15.8429 | 7.1424 | 4.199 | 5.6325 | 5.0714 | 3.7388 | 4.4045 | 5.1838 | 7.8733 | 5.1141 | 10.5353 | 15.8429 | 3 | Activator | 15.6525 | 23 | 10 | Partial curve; partial efficacy; poor fit | -4.8054 | 1.1 | 0.8952 | |||||||||||||||||
| 1 | Inactive | 0.9876 | 10.8506 | 0 | -6.0054 | 4.9549 | 0.4386 | 5.5 | -5.3506 | 4 | 0 0 0 0 0 0 0 0 0 0 1 | -4.9934 | 4.0889 | -8.0957 | -6.0136 | 3.5833 | -8.3158 | -11.9588 | -9.7356 | 3.0283 | 5.794 | 4.4051 | -4.9934 | 3 | Activator | 7.0E-4 | 22.0139 | 10 | Complete curve; partial efficacy; poor fit | -9.1554 | 4.9549 | 0.9436 | |||||||||||||||||
| 3 | Activator | 15.6525 | 23 | 10 | Partial curve; partial efficacy; poor fit | -4.8054 | 1 | 0.9012 | 28 | 5 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 22.8149 | 3.1061 | 4.3224 | 4.627 | 4.3184 | 5.3482 | 7.5816 | 8.1192 | 6.8293 | 10.6579 | 11.7776 | 22.8149 | 1 | Inactive | 6.2314 | 27.6114 | 0 | -5.2054 | 0.5 | 0.9123 | |||||||||||||||||
| 1 | Inhibitor | 4.4115 | 40.2829 | 0 | Partial curve; partial efficacy | -5.3554 | 0.5 | 0.9491 | -45.0866 | -4.8037 | -2.2 | 0 0 0 0 0 0 0 0 0 0 0 | -32.2003 | -3.1697 | -5.1907 | -5.3183 | -9.7079 | -10.4207 | -11.5804 | -12.3611 | -15.3201 | -23.6232 | -34.1565 | -32.2003 | 1 | Inactive | 0.3504 | 9.4215 | 0 | -6.4554 | 1.1 | 0.8792 |
| Rep1ABLNHIBITKGP-Outcome | Rep1ABLNHIBITKGP-Phenotype | Rep1ABLNHIBITKGP-Potency | Rep1ABLNHIBITKGP-Efficacy | Rep1ABLNHIBITKGP-Analysis Comment | Rep1ABLNHIBITKGP-Activity_Score | Rep1ABLNHIBITKGP-Curve_Description | Rep1ABLNHIBITKGP-Fit_LogAC50 | Rep1ABLNHIBITKGP-Fit_HillSlope | Rep1ABLNHIBITKGP-Fit_R2 | Rep1ABLNHIBITKGP-Fit_InfiniteActivity | Rep1ABLNHIBITKGP-Fit_ZeroActivity | Rep1ABLNHIBITKGP-Fit_CurveClass | Rep1ABLNHIBITKGP-Excluded_Points | Rep1ABLNHIBITKGP-Max_Response | Rep1ABLNHIBITKGP-Activity at 0.0000973841 uM | Rep1ABLNHIBITKGP-Activity at 0.0002921522 uM | Rep1ABLNHIBITKGP-Activity at 0.0005695054 uM | Rep1ABLNHIBITKGP-Activity at 0.0009722003 uM | Rep1ABLNHIBITKGP-Activity at 0.00171 uM | Rep1ABLNHIBITKGP-Activity at 0.00292 uM | Rep1ABLNHIBITKGP-Activity at 0.00438 uM | Rep1ABLNHIBITKGP-Activity at 0.00873 uM | Rep1ABLNHIBITKGP-Activity at 0.013 uM | Rep1ABLNHIBITKGP-Activity at 0.026 uM | Rep1ABLNHIBITKGP-Activity at 0.039 uM | Rep1ABLNHIBITKGP-Activity at 0.079 uM | Rep1ABLNHIBITKGP-Activity at 0.118 uM | Rep1ABLNHIBITKGP-Activity at 0.236 uM | Rep1ABLNHIBITKGP-Activity at 0.355 uM | Rep1ABLNHIBITKGP-Activity at 0.707 uM | Rep1ABLNHIBITKGP-Activity at 1.065 uM | Rep1ABLNHIBITKGP-Activity at 2.122 uM | Rep1ABLNHIBITKGP-Activity at 3.195 uM | Rep1ABLNHIBITKGP-Activity at 6.367 uM | Rep1ABLNHIBITKGP-Activity at 9.584 uM | Rep1ABLNHIBITKGP-Activity at 19.13 uM | Rep1ABLNHIBITKGP-Activity at 28.75 uM | Rep1ABLNHIBITKGP-Activity at 46.00 uM | Rep1ABLNHIBITKGP-Activity at 57.50 uM | Rep2ABLNHIBITKGP-Outcome | Rep2ABLNHIBITKGP-Phenotype | Rep2ABLNHIBITKGP-Potency | Rep2ABLNHIBITKGP-Efficacy | Rep2ABLNHIBITKGP-Analysis Comment | Rep2ABLNHIBITKGP-Activity_Score | Rep2ABLNHIBITKGP-Curve_Description | Rep2ABLNHIBITKGP-Fit_LogAC50 | Rep2ABLNHIBITKGP-Fit_HillSlope | Rep2ABLNHIBITKGP-Fit_R2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Inhibitor | 0.7695 | 96.8599 | 88 | Complete curve; high efficacy | -6.1138 | 1.1 | 0.9936 | -97.8599 | -1 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -95.6159 | 44.1204 | -3.4537 | -6.3709 | 2.9675 | -5.0331 | -25.2326 | -48.5919 | -71.9428 | -89.3164 | -96.5088 | -95.6159 | 2 | Inhibitor | 1.2195 | 117.7518 | 88 | Complete curve; high efficacy | -5.9138 | 0.7 | 0.9811 | ||||||||||||||||
| 3 | Inhibitor | 6.8578 | 64.9127 | 10 | Complete curve; partial efficacy; poor fit | -5.1638 | 2.3332 | 0.9672 | -62.4127 | 2.5 | -1.4 | 1 0 0 0 0 0 0 0 0 0 0 | -59.8157 | 49.5242 | 12.3168 | 4.1235 | -4.9259 | 0.4231 | 4.8976 | 0.8243 | -5.1605 | -24.3189 | -61.0404 | -59.8157 | 2 | Inhibitor | 13.6831 | 95.2393 | 42 | Partial curve; partial efficacy | -4.8638 | 1 | 0.9751 | ||||||||||||||||
| 3 | Inhibitor | 17.226 | 88.4114 | 10 | Partial curve; partial efficacy; poor fit | -4.7638 | 0.9 | 0.9738 | -87.9114 | 0.5 | -2.4 | 1 0 0 0 0 0 0 0 0 0 0 | -66.9783 | 45.186 | 1.384 | -8.5607 | 2.6064 | 2.1843 | -0.9706 | -1.8311 | -10.9412 | -28.6993 | -41.8493 | -66.9783 | 3 | Inhibitor | 17.226 | 73.4871 | 21 | Partial curve; partial efficacy | -4.7638 | 1 | 0.9654 | ||||||||||||||||
| 2 | Inhibitor | 4.855 | 100.2985 | 84 | Complete curve; high efficacy | -5.3138 | 1 | 0.9905 | -99.7985 | 0.5 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -92.9223 | 48.8886 | -5.7317 | -2.0091 | 3.398 | 2.7538 | 0.3859 | -15.1293 | -31.6111 | -53.5588 | -80.4029 | -92.9223 | 2 | Inhibitor | 8.6335 | 90.9101 | 43 | Partial curve; high efficacy | -5.0638 | 1.2475 | 0.9601 | ||||||||||||||||
| 2 | Inhibitor | 0.7695 | 106.4511 | 89 | Complete curve; high efficacy | -6.1138 | 1.111 | 0.9911 | -109.9511 | -3.5 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -107.7952 | 53.5706 | -12.1008 | -2.6557 | 0.5333 | -8.8193 | -29.2183 | -54.1546 | -81.4141 | -105.7272 | -105.3085 | -107.7952 | 2 | Inhibitor | 0.9687 | 99.7881 | 87 | Complete curve; high efficacy | -6.0138 | 1.21 | 0.9968 | ||||||||||||||||
| 2 | Inhibitor | 0.0217 | 100.5944 | 95 | Complete curve; high efficacy | -7.6638 | 1.2475 | 0.9958 | -97.2373 | 3.3571 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -96.4563 | 41.2719 | -0.5358 | -24.7071 | -54.3307 | -80.6375 | -90.8644 | -94.2534 | -95.5393 | -99.0038 | -100.0384 | -96.4563 | 2 | Inhibitor | 0.0344 | 114.4477 | 94 | Complete curve; high efficacy | -7.4638 | 0.9 | 0.9932 | ||||||||||||||||
| 2 | Inhibitor | 0.0306 | 127.583 | 97 | Complete curve; high efficacy | -7.5138 | 1.21 | 0.9767 | -111.583 | 16 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -110.0501 | 41.1638 | 20.8149 | -3.3628 | -57.4336 | -72.9892 | -96.2801 | -108.774 | -113.4217 | -114.7974 | -114.3247 | -110.0501 | 2 | Inhibitor | 0.0545 | 104.6411 | 94 | Complete curve; high efficacy | -7.2638 | 1.1341 | 0.998 | ||||||||||||||||
| 2 | Inhibitor | 3.437 | 90.2973 | 84 | Complete curve; high efficacy | -5.4638 | 1.6604 | 0.9691 | -86.7973 | 3.5 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -84.5978 | 57.8943 | -12.0624 | 10.3263 | 11.0062 | 7.9817 | -2.5433 | 0.3123 | -25.9693 | -61.7167 | -84.3117 | -84.5978 | 2 | Inhibitor | 5.4474 | 105.8032 | 84 | Complete curve; high efficacy | -5.2638 | 1.111 | 0.9898 | ||||||||||||||||
| 3 | Inhibitor | 7.6946 | 56.56 | 10 | Complete curve; partial efficacy; poor fit | -5.1138 | 2.2526 | 0.9935 | -64.2642 | -7.7042 | -1.4 | 1 0 0 0 0 0 0 0 0 0 0 | -63.2076 | 41.0861 | -4.7535 | -5.1979 | -9.8641 | -9.8419 | -8.9238 | -7.831 | -11.9616 | -29.2505 | -58.1842 | -63.2076 | 3 | Inhibitor | 9.6869 | 69.4997 | 22 | Complete curve; partial efficacy | -5.0138 | 1.6604 | 0.9877 | ||||||||||||||||
| 2 | Inhibitor | 0.0545 | 108.7256 | 95 | Complete curve; high efficacy | -7.2638 | 1.2475 | 0.9982 | -107.7663 | 0.9593 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -103.0706 | 46.1874 | -0.8672 | -8.9952 | -31.5787 | -64.6045 | -92.6977 | -103.9198 | -108.2866 | -108.8548 | -108.6303 | -103.0706 | 2 | Inhibitor | 0.0611 | 117.5814 | 95 | Complete curve; high efficacy | -7.2138 | 1.111 | 0.9972 | ||||||||||||||||
| 2 | Inhibitor | 2.1686 | 104.91 | 86 | Complete curve; high efficacy | -5.6638 | 0.9 | 0.9968 | -104.91 | 0 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -96.6022 | 41.2147 | 1.8272 | -2.1162 | 1.1313 | -7.2453 | -14.5314 | -28.0384 | -51.5051 | -75.1762 | -95.321 | -96.6022 | 2 | Inhibitor | 2.4332 | 99.1819 | 85 | Complete curve; high efficacy | -5.6138 | 1.3723 | 0.9961 | ||||||||||||||||
| 2 | Inhibitor | 1.9328 | 112.5254 | 87 | Complete curve; high efficacy | -5.7138 | 1.3443 | 0.9969 | -115.5254 | -3 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -112.5979 | 50.7256 | -9.195 | 0.2092 | -1.6625 | -4.2657 | -8.2227 | -27.3861 | -64.013 | -95.4736 | -112.3939 | -112.5979 | 2 | Inhibitor | 2.4332 | 98.3371 | 86 | Complete curve; high efficacy | -5.6138 | 1.7529 | 0.9622 | ||||||||||||||||
| 2 | Inhibitor | 1.9328 | 92.5709 | 86 | Complete curve; high efficacy | -5.7138 | 1.2876 | 0.986 | -92.5709 | 0 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -85.7901 | 46.9787 | 3.1372 | -0.5672 | -2.6279 | -4.5321 | -3.2993 | -19.0615 | -53.0618 | -70.466 | -97.0345 | -85.7901 | 2 | Inhibitor | 3.437 | 103.0621 | 85 | Complete curve; high efficacy | -5.4638 | 1.331 | 0.9935 | ||||||||||||||||
| 2 | Inhibitor | 0.7695 | 120.3161 | 89 | Complete curve; high efficacy | -6.1138 | 1.1 | 0.9964 | -116.3161 | 4 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -114.0354 | 47.0317 | 0.4047 | 4.8432 | 5.0167 | -9.4501 | -21.034 | -54.8817 | -81.9062 | -108.647 | -113.4948 | -114.0354 | 2 | Inhibitor | 1.3683 | 106.5036 | 87 | Complete curve; high efficacy | -5.8638 | 1.21 | 0.9938 | ||||||||||||||||
| 2 | Inhibitor | 4.327 | 109.2921 | 85 | Complete curve; high efficacy | -5.3638 | 1 | 0.9931 | -108.7921 | 0.5 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -99.6265 | 37.0501 | -0.8336 | 3.7482 | -2.6571 | -2.4567 | -1.0858 | -21.4344 | -32.4442 | -65.0445 | -90.958 | -99.6265 | 2 | Inhibitor | 5.4474 | 106.1276 | 84 | Complete curve; high efficacy | -5.2638 | 1.111 | 0.938 | ||||||||||||||||
| 2 | Inhibitor | 6.112 | 75.4483 | 63 | Complete curve; partial efficacy | -5.2138 | 1.5095 | 0.9906 | -77.4483 | -2 | -1.2 | 1 0 0 0 0 0 0 0 0 0 0 | -75.3932 | 38.9496 | -0.3602 | -4.0024 | 0.0833 | 2.6944 | -8.4529 | -5.8093 | -14.2337 | -40.7585 | -65.9145 | -75.3932 | 2 | Inhibitor | 7.6946 | 93.305 | 43 | Partial curve; partial efficacy | -5.1138 | 0.8 | 0.9396 | ||||||||||||||||
| 2 | Inhibitor | 0.0969 | 92.3421 | 93 | Complete curve; high efficacy | -7.0138 | 2.2526 | 0.9965 | -101.0679 | -8.7258 | -1.1 | 1 0 0 0 0 0 0 0 0 0 0 | -98.9117 | 51.4906 | -12.1701 | -5.6048 | -13.1487 | -44.5494 | -94.7513 | -98.4445 | -102.7113 | -101.0107 | -99.6301 | -98.9117 | 2 | Inhibitor | 0.2169 | 88.5812 | 91 | Complete curve; high efficacy | -6.6638 | 1.8617 | 0.9946 | ||||||||||||||||
| 3 | Inhibitor | 1.7226 | 46.5767 | 23 | Complete curve; partial efficacy | -5.7638 | 1.8617 | 0.9368 | -46.0767 | 0.5 | -1.2 | 1 0 0 0 0 0 0 0 0 0 0 | -36.5194 | 30.3533 | 7.4909 | -2.9335 | 1.4709 | -3.0834 | -1.657 | -9.3033 | -23.6128 | -45.3373 | -54.2465 | -36.5194 | 3 | Inhibitor | 1.7226 | 37.8671 | 22 | Complete curve; partial efficacy | -5.7638 | 1.7885 | 0.8766 | ||||||||||||||||
| 3 | Inhibitor | 3.0633 | 72.2794 | 23 | Complete curve; partial efficacy | -5.5138 | 1.331 | 0.9678 | -68.7794 | 3.5 | -1.2 | 1 0 0 0 0 0 0 0 0 0 0 | -62.4787 | 39.3427 | -5.6993 | -0.1576 | 10.7082 | 5.898 | 5.9104 | -9.682 | -21.0286 | -48.1079 | -67.2853 | -62.4787 | 2 | Inhibitor | 6.112 | 76.8155 | 63 | Complete curve; partial efficacy | -5.2138 | 1.4163 | 0.91 | ||||||||||||||||
| 3 | Inhibitor | 5.4474 | 32.5493 | 10 | Partial curve; partial efficacy; poor fit | -5.2638 | 2.2526 | 0.9891 | -34.5493 | -2 | -2.4 | 1 0 0 0 0 0 0 0 0 0 1 | 4.1229 | 38.5258 | -3.821 | -2.1815 | -2.472 | -1.2214 | 0.1387 | -3.4014 | -5.3299 | -21.8266 | -32.1244 | 4.1229 | 1 | Inactive | 6.112 | 25.0411 | 0 | -5.2138 | 1.6924 | 0.6155 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 1.1 | Kd | = | 1100 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.2 | Kd | = | 200 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 5.4 | Kd | = | 5400 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| Rep1ABLNHIBITWithATPSDR-Outcome | Rep1ABLNHIBITWithATPSDR-Phenotype | Rep1ABLNHIBITWithATPSDR-Potency | Rep1ABLNHIBITWithATPSDR-Efficacy | Rep1ABLNHIBITWithATPSDR-Analysis Comment | Rep1ABLNHIBITWithATPSDR-Activity_Score | Rep1ABLNHIBITWithATPSDR-Curve_Description | Rep1ABLNHIBITWithATPSDR-Fit_LogAC50 | Rep1ABLNHIBITWithATPSDR-Fit_HillSlope | Rep1ABLNHIBITWithATPSDR-Fit_R2 | Rep1ABLNHIBITWithATPSDR-Fit_InfiniteActivity | Rep1ABLNHIBITWithATPSDR-Fit_ZeroActivity | Rep1ABLNHIBITWithATPSDR-Fit_CurveClass | Rep1ABLNHIBITWithATPSDR-Excluded_Points | Rep1ABLNHIBITWithATPSDR-Max_Response | Rep1ABLNHIBITWithATPSDR-Activity at 0.0000973841 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.0002921522 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.0005695054 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.0009722003 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.00171 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.00292 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.00438 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.00873 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.013 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.026 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.039 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.079 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.118 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.236 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.355 uM | Rep1ABLNHIBITWithATPSDR-Activity at 0.707 uM | Rep1ABLNHIBITWithATPSDR-Activity at 1.065 uM | Rep1ABLNHIBITWithATPSDR-Activity at 2.122 uM | Rep1ABLNHIBITWithATPSDR-Activity at 3.195 uM | Rep1ABLNHIBITWithATPSDR-Activity at 6.367 uM | Rep1ABLNHIBITWithATPSDR-Activity at 9.584 uM | Rep1ABLNHIBITWithATPSDR-Activity at 19.13 uM | Rep1ABLNHIBITWithATPSDR-Activity at 28.75 uM | Rep1ABLNHIBITWithATPSDR-Activity at 46.00 uM | Rep1ABLNHIBITWithATPSDR-Activity at 57.50 uM | Rep2ABLNHIBITWithATPSDR-Outcome | Rep2ABLNHIBITWithATPSDR-Phenotype | Rep2ABLNHIBITWithATPSDR-Potency | Rep2ABLNHIBITWithATPSDR-Efficacy | Rep2ABLNHIBITWithATPSDR-Analysis Comment | Rep2ABLNHIBITWithATPSDR-Activity_Score | Rep2ABLNHIBITWithATPSDR-Curve_Description | Rep2ABLNHIBITWithATPSDR-Fit_LogAC50 | Rep2ABLNHIBITWithATPSDR-Fit_HillSlope | Rep2ABLNHIBITWithATPSDR-Fit_R2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | Activator | 0.3437 | 34.9866 | 23 | Complete curve; partial efficacy | -6.4638 | 1 | 0.9765 | 33 | -1.9866 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 31.5578 | -3.7388 | -2.9095 | 0.214 | 5.4625 | 0.2318 | 13.1714 | 20.6836 | 28.2924 | 31.8203 | 32.7762 | 31.5578 | 3 | Activator | 0.0769 | 38.9012 | 23 | Complete curve; partial efficacy | -7.1138 | 0.5 | 0.981 | ||||||||||||||||
| 3 | Activator | 0.0386 | 20.5 | 10 | Complete curve; partial efficacy; poor fit | -7.4138 | 1.21 | 0.9569 | 22 | 1.5 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 22.518 | 0.9193 | 5.2546 | 0.7602 | 10.0415 | 17.1553 | 19.332 | 19.1037 | 23.7692 | 22.759 | 22.0652 | 22.518 | 1 | Inactive | 0.0243 | 20.2945 | 0 | -7.6138 | 1.1 | 0.9862 | |||||||||||||||||
| 1 | Inactive | 0.9687 | 35.0587 | 0 | -6.0138 | 0.3 | 0.8605 | 26 | -9.0587 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 19.5708 | -6.2989 | -3.4107 | -0.5594 | -2.815 | 2.4206 | 11.9457 | 1.236 | 11.5446 | 11.5111 | 16.8202 | 19.5708 | 3 | Activator | 3.0633 | 28.6391 | 10 | Partial curve; partial efficacy; poor fit | -5.5138 | 0.4 | 0.965 | |||||||||||||||||
| 3 | Activator | 1.9328 | 48.228 | 23 | Complete curve; partial efficacy | -5.7138 | 0.8 | 0.95 | 42.0357 | -6.1923 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 35.3789 | -8.9103 | -7.3249 | -4.6204 | -1.7526 | -1.9605 | 0.832 | 12.8088 | 10.0087 | 33.2981 | 39.1373 | 35.3789 | 3 | Activator | 2.1686 | 48.2331 | 23 | Complete curve; partial efficacy | -5.6638 | 1.5095 | 0.9717 | ||||||||||||||||
| 3 | Activator | 0.1933 | 40.5719 | 23 | Complete curve; partial efficacy | -6.7138 | 0.3 | 0.9006 | 30 | -10.5719 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 22.5887 | -3.5262 | -5.4766 | 1.9784 | 5.7439 | 12.4545 | 4.7626 | 10.6294 | 17.0786 | 23.4135 | 24.1532 | 22.5887 | 3 | Activator | 0.9687 | 31.8953 | 10 | Complete curve; partial efficacy; poor fit | -6.0138 | 0.4 | 0.9637 | ||||||||||||||||
| 3 | Activator | 4.327 | 46.8318 | 22 | Partial curve; partial efficacy | -5.3638 | 0.4 | 0.8935 | 44.5662 | -2.2656 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 33.8576 | -1.2123 | -2.3046 | 1.1392 | 3.0173 | 8.6451 | 17.2312 | 5.4258 | 13.5432 | 22.8393 | 30.1546 | 33.8576 | 3 | Activator | 4.855 | 40.9138 | 22 | Partial curve; partial efficacy | -5.3138 | 0.5 | 0.9619 | ||||||||||||||||
| 3 | Activator | 1.9328 | 47.1798 | 23 | Complete curve; partial efficacy | -5.7138 | 0.7 | 0.9382 | 48.8056 | 1.6258 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 41.8913 | -1.5618 | 2.3088 | 1.8314 | 5.1097 | 9.2272 | 17.1468 | 8.0081 | 25.8312 | 37.9356 | 42.9467 | 41.8913 | 3 | Activator | 2.4332 | 40.0188 | 22 | Complete curve; partial efficacy | -5.6138 | 1.9673 | 0.9894 | ||||||||||||||||
| 3 | Activator | 1.7226 | 33.0444 | 22 | Complete curve; partial efficacy | -5.7638 | 0.9 | 0.9328 | 34.5 | 1.4556 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 31.3449 | -2.9537 | 0.4334 | 1.4451 | 5.1248 | 11.3282 | 2.4855 | 10.7819 | 19.0159 | 28.0061 | 32.0205 | 31.3449 | 3 | Activator | 1.7226 | 32.4282 | 22 | Complete curve; partial efficacy | -5.7638 | 1.21 | 0.9917 | ||||||||||||||||
| 3 | Activator | 1.3683 | 42.4892 | 10 | Complete curve; partial efficacy; poor fit | -5.8638 | 0.4 | 0.9513 | 37 | -5.4892 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 28.8606 | -4.1577 | -1.4067 | 0.1604 | 1.5105 | 2.571 | 11.2862 | 16.1397 | 11.2004 | 23.1197 | 27.963 | 28.8606 | 3 | Activator | 2.4332 | 33.2165 | 10 | Complete curve; partial efficacy; poor fit | -5.6138 | 0.7 | 0.9572 | ||||||||||||||||
| 3 | Activator | 21.6863 | 34.4046 | 10 | Partial curve; partial efficacy; poor fit | -4.6638 | 0.6 | 0.8003 | 30 | -4.4046 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 22.603 | -2.2249 | -5.7538 | -4.9239 | -3.1946 | -2.8651 | -4.725 | 0.1164 | 10.5148 | 1.4413 | 7.7914 | 22.603 | 1 | Inactive | 9.6869 | 20.6165 | 0 | -5.0138 | 0.7 | 0.8872 | |||||||||||||||||
| 3 | Activator | 0.3437 | 36.0692 | 10 | Complete curve; partial efficacy; poor fit | -6.4638 | 0.4 | 0.9418 | 27 | -9.0692 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 23.6129 | -5.4744 | -3.4476 | -3.4133 | 0.0168 | 2.4693 | 9.2031 | 16.5895 | 9.5173 | 17.8497 | 22.0966 | 23.6129 | 3 | Activator | 1.2195 | 30.2554 | 10 | Complete curve; partial efficacy; poor fit | -5.9138 | 0.5 | 0.9414 | ||||||||||||||||
| 3 | Activator | 7.6946 | 41.2283 | 21 | Partial curve; partial efficacy | -5.1138 | 0.5 | 0.9231 | 40 | -1.2283 | 2.2 | 0 0 0 0 0 0 0 0 0 0 0 | 30.3496 | -1.4403 | -0.6018 | -0.8358 | 1.304 | 2.6257 | 5.956 | 14.4741 | 7.6603 | 14.1714 | 26.5702 | 30.3496 | 3 | Activator | 6.112 | 35.5193 | 21 | Partial curve; partial efficacy | -5.2138 | 0.8 | 0.9845 | ||||||||||||||||
| 3 | Activator | 0.0863 | 31.3864 | 10 | Complete curve; partial efficacy; poor fit | -7.0638 | 0.5 | 0.9174 | 27.5 | -3.8864 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 24.4602 | -1.572 | 0.8126 | 3.4938 | 13.4302 | 4.774 | 15.1856 | 21.0862 | 24.0674 | 24.468 | 26.0623 | 24.4602 | 3 | Activator | 0.1087 | 23.4757 | 10 | Complete curve; partial efficacy; poor fit | -6.9638 | 1.4641 | 0.9785 | ||||||||||||||||
| 1 | Inactive | 1.7226 | 18.3378 | 0 | -5.7638 | 1.3723 | 0.9054 | 16.5 | -1.8378 | 4 | 0 0 0 0 0 0 0 0 0 0 0 | 20.2865 | -2.4417 | 0.0222 | -1.4876 | -1.7704 | -3.6148 | -0.1949 | 2.2633 | 7.9375 | 15.9573 | 10.0395 | 20.2865 | 3 | Activator | 19.3279 | 31.5456 | 10 | Partial curve; partial efficacy; poor fit | -4.7138 | 0.8 | 0.9277 | |||||||||||||||||
| 3 | Activator | 7.6946 | 30.9292 | 10 | Partial curve; partial efficacy; poor fit | -5.1138 | 0.5 | 0.8723 | 28 | -2.9292 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 20.2366 | -4.1077 | -2.4026 | -1.1392 | -0.6955 | -1.6501 | 4.449 | 8.9699 | 0.3447 | 11.6762 | 17.5891 | 20.2366 | 3 | Activator | 6.8578 | 30.0517 | 10 | Partial curve; partial efficacy; poor fit | -5.1638 | 0.6 | 0.9696 | ||||||||||||||||
| 3 | Activator | 1.6786 | 32.7547 | 22 | Complete curve; partial efficacy | -5.7751 | 1.331 | 0.9323 | 33.5 | 0.7453 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 31.5621 | -1.6182 | -3.5456 | -0.3382 | 0.9294 | 3.0455 | 10.4915 | 2.7279 | 10.6336 | 25.8001 | 30.7004 | 31.5621 | 3 | Activator | 0.8413 | 34.5676 | 23 | Complete curve; partial efficacy | -6.0751 | 1 | 0.9883 | ||||||||||||||||
| 3 | Activator | 0.0306 | 24 | 10 | Complete curve; partial efficacy; poor fit | -7.5138 | 1.6266 | 0.9469 | 27 | 3 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 23.6781 | 1.7674 | 8.1108 | 1.8977 | 15.0595 | 23.0236 | 26.2816 | 27.2991 | 29.8601 | 26.7795 | 27.1892 | 23.6781 | 3 | Activator | 0.0217 | 18.5 | 10 | Complete curve; partial efficacy; poor fit | -7.6638 | 3.0654 | 0.887 | ||||||||||||||||
| 3 | Activator | 0.2169 | 35.6451 | 24 | Complete curve; partial efficacy | -6.6638 | 0.6 | 0.9779 | 32.5 | -3.1451 | 1.2 | 0 0 0 0 0 0 0 0 0 0 0 | 29.8204 | -1.1705 | -2.2042 | 0.0416 | 6.6682 | 11.7493 | 11.3844 | 20.0797 | 27.7314 | 28.1122 | 31.405 | 29.8204 | 3 | Activator | 0.3063 | 33.4978 | 23 | Complete curve; partial efficacy | -6.5138 | 0.9 | 0.9691 | ||||||||||||||||
| 3 | Activator | 1.0869 | 35.1147 | 10 | Partial curve; partial efficacy; poor fit | -5.9638 | 0.4 | 0.883 | 28.5 | -6.6147 | 2.4 | 0 0 0 0 0 0 0 0 0 0 0 | 24.4258 | -3.3084 | -3.2173 | -3.8456 | -2.5657 | 0.7528 | 8.7385 | 16.9557 | 7.8725 | 12.9208 | 21.2955 | 24.4258 | 3 | Activator | 5.4474 | 35.6712 | 10 | Partial curve; partial efficacy; poor fit | -5.2638 | 0.6 | 0.9714 | ||||||||||||||||
| 3 | Activator | 0.0217 | 25.2549 | 10 | Complete curve; partial efficacy; poor fit | -7.6638 | 2.3332 | 0.9721 | 26 | 0.7451 | 1.4 | 0 0 0 0 0 0 0 0 0 0 0 | 25.5723 | -1.0458 | 4.4909 | 0.857 | 18.0311 | 23.6882 | 24.0783 | 24.9472 | 26.336 | 27.6227 | 26.6444 | 25.5723 | 3 | Activator | 0.0217 | 22.1287 | 10 | Complete curve; partial efficacy; poor fit | -7.6638 | 2.3332 | 0.9947 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 0.44 | Kd | = | 440 | nM |
| 10 | Kd | > | 10000 | nM |
| 2.2 | Kd | = | 2200 | nM |
| 0.05 | Kd | = | 50 | nM |
| 0.27 | Kd | = | 270 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.59 | Kd | = | 590 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 2 | Kd | = | 2000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.37 | Kd | = | 370 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.33 | Kd | = | 330 | nM |
| 0.58 | Kd | = | 580 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 3.6 | Kd | = | 3600 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 3.4 | Kd | = | 3400 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.64 | Kd | = | 640 | nM |
| 2.2 | Kd | = | 2200 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 1.2 | Kd | = | 1200 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inactive | 0 | 0 | 0 | 4 | 9.3597 | 0 | 0 | 0 | 0 | 0 | 2.2289 | 0 | 9.3597 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.8748 | -21.4867 | 4 | 4 | 0 0 0 0 0 0 0 0 | -17.0722 | 6.1042 | 2.8293 | 0 | 7.4025 | 0 | 6.1286 | 5.2151 | -17.0722 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -8.275 | 1.1705 | 0.6611 | 2 | -6.667 | 4 | 0 0 0 0 0 0 0 0 | -1.0776 | -6.3892 | -2.9698 | -1.7372 | 5.874 | 0.3532 | 2.419 | 2.3477 | -1.0776 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | -4.425 | 4.9549 | 0.4933 | -23.5282 | -3 | 4 | 0 0 0 0 0 0 0 0 | -17.9402 | 0.3948 | -8.1012 | -10.4184 | -5.5544 | 1.8102 | -4.7765 | 5.7051 | -17.9402 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 7.8331 | 0 | 0 | 9.3496 | 0 | 8.3936 | 8.8574 | 0 | QC'd by Sequoia | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 2.1346 | 2.0873 | 2.8787 | 2.1981 | 0 | 1.0717 | 0 | 0 | QC'd by SIGMA | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 6.7477 | 0 | 7.719 | 6.3706 | 0 | 0 | 0 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 1.3259 | 8.1273 | 0 | 0 | 7.3085 | 6.1485 | 9.7634 | 0 | 1.3259 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -6.775 | 4.9549 | 0.7871 | -25.4234 | -14.7892 | 4 | 1 0 0 0 0 0 0 1 | -14.8266 | -40.4001 | -18.8558 | -14.3881 | -11.9076 | -28.2695 | -23.675 | -23.6904 | -14.8266 | QC'd by Microsource | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 0 | 3.2238 | 5.3823 | 0 | 7.5034 | 0 | 0 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | -4.475 | 4.9549 | 0.4377 | -10.0741 | 2 | 4 | 0 0 0 0 0 0 0 0 | -7.9784 | 0 | 0 | 6.8904 | -2.1283 | 0 | 0.7614 | 9.8865 | -7.9784 | QC'd by Labotest | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | -2.1184 | 4.7394 | 4.4107 | -0.6138 | 5.1674 | 0 | 2.3218 | -1.3941 | -2.1184 | QC'd by Microsource | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0.2342 | 2.9725 | 5.1318 | 0 | 2.0235 | 0 | 0.0589 | 0 | QC'd by Enzo | ||||||||||||||||||||||||||
| Inactive | 0 | -8.725 | 0.6 | 0.7945 | 4.5 | -11.9886 | 4 | 0 0 0 0 0 0 0 1 | -9.0185 | -8.3238 | -0.4567 | 0.9031 | 0.0721 | 3.3394 | 7.7262 | 3.0826 | -9.0185 | QC'd by Vitas | ||||||||||||||||||||||
| Inactive | 0 | -9.125 | 4.9549 | 0.5569 | 5 | -5.3552 | 4 | 0 0 0 0 0 0 0 1 | -2.6103 | -2.796 | 6.9995 | 3.4228 | 1.6101 | 8.0983 | 7.0134 | 2.0138 | -2.6103 | QC'd by Specs | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0.9896 | 0 | 0 | 9.6344 | 0 | 0 | 4.2786 | 0 | 0.9896 | QC'd by GVK | ||||||||||||||||||||||||||
| Inactive | 0 | -5.525 | 4.095 | 0.6337 | -3.6963 | 3 | 4 | 0 0 0 0 0 0 0 0 | -3.4671 | 3.2926 | 6.7211 | 0 | 4.9171 | 0 | 2.2046 | -3.4969 | -3.4671 | QC'd by Prestwick | ||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 3.1269 | 3.0732 | 0 | 6.5383 | 2.8274 | 0 | -3.4128 | 8.3114 | 3.1269 | QC'd by Labotest | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 0 | 0 | 2.578 | 6.6592 | 0 | 0 | 0 | 3.3663 | 0 | QC'd by Prestwick | ||||||||||||||||||||||||||
| Inactive | 0 | 0 | 0 | 4 | 2.6761 | 0 | 0 | 8.9375 | 0 | 0 | 0.408 | 0 | 2.6761 | QC'd by Prestwick Chemical; Inc. |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 1.9 | Kd | = | 1900 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.74 | Kd | = | 740 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 2 | Kd | = | 2000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.24 | Kd | = | 240 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062633 uM | Activity at 0.0000234000 uM | Activity at 0.0000299492 uM | Activity at 0.0000680174 uM | Activity at 0.0001469594 uM | Activity at 0.0003236290 uM | Activity at 0.0006759500 uM | Activity at 0.00129 uM | Activity at 0.00271 uM | Activity at 0.00485 uM | Activity at 0.00758 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.355 uM | Activity at 0.588 uM | Activity at 1.399 uM | Activity at 1.898 uM | Activity at 4.965 uM | Activity at 9.229 uM | Activity at 17.27 uM | Activity at 44.90 uM | Activity at 91.89 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Inhibitor | 0.0015 | 95.0131 | 100 | Complete curve; high efficacy | -8.8295 | 4.9549 | 0.995 | -92.9859 | 2.0272 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.2587 | -1.6791 | -84.9271 | -90.9202 | -90.8631 | -90.7375 | -92.2911 | -92.6732 | -94.1019 | -94.0673 | -96.0913 | -96.2587 | QC'd by SIGMA | ||||||||||||||||
| Inhibitor | 0.0017 | 96.0144 | 100 | Complete curve; high efficacy | -8.7683 | 3.2475 | 0.9987 | -95.3786 | 0.6358 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9294 | 1.7123 | -0.1391 | -34.4453 | -93.3159 | -93.9442 | -94.1795 | -94.3745 | -94.7424 | -94.9325 | -95.6129 | -96.9294 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0017 | 101.1335 | 100 | Complete curve; high efficacy | -8.7683 | 4.5045 | 0.9988 | -96.4557 | 4.6778 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.6254 | 2.9383 | 5.3252 | -23.8352 | -93.6078 | -94.3407 | -94.7755 | -96.5382 | -96.9802 | -98.093 | -97.488 | -98.6254 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0014 | 95.7664 | 100 | Complete curve; high efficacy | -8.8683 | 3.0654 | 0.9932 | -91.7312 | 4.0352 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -94.3736 | 0 | 6.5073 | -50.3576 | -85.2142 | -89.4583 | -90.3553 | -90.6328 | -93.2878 | -91.6178 | -92.6738 | -94.3736 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0027 | 92.0567 | 99 | Complete curve; high efficacy | -8.575 | 3.99 | 0.9971 | -93.082 | -1.0254 | -1.1 | 0 0 0 0 0 0 0 0 | -97.5703 | -1.153 | -56.5542 | -91.9507 | -92.331 | -93.0234 | -92.9105 | -92.2466 | -97.5703 | QC'd by Alfa Aesar | |||||||||||||||||||
| Inhibitor | 0.0027 | 86.1528 | 99 | Complete curve; high efficacy | -8.575 | 4.9549 | 0.9984 | -92.0573 | -5.9045 | -1.1 | 0 0 0 0 0 0 0 0 | -92.9872 | -5.0961 | -62.3948 | -91.5014 | -91.2009 | -92.0539 | -90.8793 | -91.9519 | -92.9872 | QC'd by Microsource | |||||||||||||||||||
| Inhibitor | 0.0021 | 98.4878 | 99 | Complete curve; high efficacy | -8.675 | 4.5045 | 0.9983 | -91.9795 | 6.5083 | -1.1 | 0 0 0 0 0 0 0 0 | -94.0485 | 5.8681 | -73.3835 | -89.9758 | -90.798 | -91.9458 | -91.2065 | -93.7497 | -94.0485 | QC'd by Bosche | |||||||||||||||||||
| Inhibitor | 7.0E-4 | 82.7334 | 99 | Complete curve; high efficacy | -9.175 | 0.6 | 0.8847 | -82.6567 | 0.0767 | -1.1 | 0 0 0 0 0 0 0 0 | -94.3569 | -37.5208 | -62.7186 | -72.7916 | -74.3825 | -79.8918 | -76.6331 | -78.5528 | -94.3569 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0037 | 95.0819 | 99 | Complete curve; high efficacy | -8.4362 | 1.2221 | 0.9994 | -94.5205 | 0.5614 | -1.1 | 0 0 0 0 0 0 0 | -93.7704 | -1.1631 | 0.6157 | -11.9264 | -47.6173 | -82.383 | -92.7843 | -93.7704 | QC'd by Adooq | ||||||||||||||||||||
| Inhibitor | 0.0033 | 94.0479 | 99 | Complete curve; high efficacy | -8.4795 | 3.5117 | 0.9958 | -93.9623 | 0.0856 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -97.8774 | 1.2665 | -23.1756 | -88.8678 | -90.2585 | -91.8229 | -92.3997 | -94.1271 | -95.2991 | -93.6757 | -95.8566 | -97.8774 | QC'd by MedChem Express | ||||||||||||||||
| Inhibitor | 0.0047 | 102.0075 | 98 | Complete curve; high efficacy | -8.3295 | 2.2481 | 0.997 | -94.1763 | 7.8312 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -98.7173 | 5.6987 | -9.7434 | -65.3554 | -90.638 | -91.2058 | -92.371 | -92.7427 | -94.2549 | -94.3053 | -96.979 | -98.7173 | QC'd by GVK | ||||||||||||||||
| Inhibitor | 0.0047 | 100.429 | 98 | Complete curve; high efficacy | -8.325 | 3.6772 | 0.9994 | -93.2276 | 7.2013 | -1.1 | 0 0 0 0 0 0 0 0 | -94.7435 | 8.1328 | -8.6557 | -90.5176 | -92.1158 | -93.5383 | -93.4255 | -92.4974 | -94.7435 | QC'd by Prestwick | |||||||||||||||||||
| Inhibitor | 0.0038 | 96.7634 | 98 | Complete curve; high efficacy | -8.425 | 3.99 | 0.9994 | -92.0205 | 4.743 | -1.1 | 0 0 0 0 0 0 0 0 | -93.5167 | 4.0536 | -21.1619 | -91.8053 | -91.1174 | -91.9789 | -90.7784 | -91.2901 | -93.5167 | QC'd by Selleck | |||||||||||||||||||
| Inhibitor | 0.0045 | 90.5397 | 98 | Complete curve; high efficacy | -8.3466 | 4.5045 | 0.9995 | -92.4565 | -1.9167 | -1.1 | 0 0 0 0 0 0 0 | -93.156 | -4.128 | -89.5728 | -91.2217 | -93.3904 | -92.524 | -93.0057 | -93.156 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.2987 | 98 | Complete curve; high efficacy | -8.288 | 4.9549 | 0.9993 | -92.6581 | 5.6406 | -1.1 | 0 0 0 0 0 0 0 | -93.5941 | 0 | -91.9394 | -91.381 | -91.3804 | -93.5391 | -93.3571 | -93.5941 | QC'd by ChemieTek | ||||||||||||||||||||
| Inhibitor | 0.0052 | 98.8546 | 98 | Complete curve; high efficacy | -8.288 | 0.6 | 0.9861 | -94.1197 | 4.7349 | -1.1 | 0 0 0 0 0 0 0 | -93.9318 | -33.6729 | -64.3585 | -76.1096 | -84.2151 | -92.4038 | -93.1111 | -93.9318 | QC'd by MedChem Express | ||||||||||||||||||||
| Inhibitor | 0.004 | 86.0426 | 98 | Complete curve; high efficacy | -8.3992 | 4.5045 | 0.9996 | -92.288 | -6.2454 | -1.1 | 0 0 0 0 0 0 0 | -91.795 | -7.0299 | -86.4668 | -91.4418 | -93.2202 | -92.6549 | -92.4417 | -91.795 | QC'd by Selleck | ||||||||||||||||||||
| Inhibitor | 0.0046 | 98.0203 | 98 | Complete curve; high efficacy | -8.338 | 3.5117 | 0.9996 | -93.1684 | 4.8519 | -1.1 | 0 0 0 0 0 0 0 | -93.7644 | -11.8828 | -91.4502 | -92.2553 | -94.1095 | -92.9439 | -93.2642 | -93.7644 | QC'd by SIGMA | ||||||||||||||||||||
| Inhibitor | 0.0042 | 104.4497 | 98 | Complete curve; high efficacy | -8.3795 | 4.9549 | 0.9968 | -93.9204 | 10.5293 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.6259 | 8.6675 | 7.5142 | -90.2575 | -91.0844 | -91.1114 | -92.6871 | -93.2743 | -95.4523 | -94.079 | -95.5345 | -96.6259 | QC'd by BioAustralis | ||||||||||||||||
| Inhibitor | 0.0042 | 94.9421 | 98 | Complete curve; high efficacy | -8.3795 | 2.8473 | 0.9968 | -94.7591 | 0.183 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | -96.9399 | 0.6808 | -16.1375 | -78.234 | -91.1234 | -91.9081 | -92.3507 | -95.4781 | -97.4887 | -95.7111 | -95.4747 | -96.9399 | QC'd by ActiveBioChem |
| Phenotype | Potency | Efficacy | Analysis Comment | Activity_Score | Curve_Description | Fit_LogAC50 | Fit_HillSlope | Fit_R2 | Fit_InfiniteActivity | Fit_ZeroActivity | Fit_CurveClass | Excluded_Points | Max_Response | Activity at 0.0000062652 uM | Activity at 0.0000234000 uM | Activity at 0.0000299754 uM | Activity at 0.0000680318 uM | Activity at 0.0001469781 uM | Activity at 0.0003237363 uM | Activity at 0.0006761082 uM | Activity at 0.00130 uM | Activity at 0.00271 uM | Activity at 0.00486 uM | Activity at 0.00759 uM | Activity at 0.016 uM | Activity at 0.038 uM | Activity at 0.071 uM | Activity at 0.177 uM | Activity at 0.356 uM | Activity at 0.588 uM | Activity at 1.402 uM | Activity at 1.903 uM | Activity at 4.972 uM | Activity at 9.253 uM | Activity at 17.29 uM | Activity at 44.98 uM | Activity at 91.90 uM | Activity at 155.1 uM | Activity at 231.0 uM | Compound QC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cytotoxic | 0.008 | 82.2034 | 84 | Complete curve; high efficacy | -8.0992 | 1.01 | 0.9669 | 21.0427 | 103.2462 | -1.1 | 0 0 0 0 0 0 0 | 13.1884 | 95.4748 | 59.0672 | 35.8423 | 31.6652 | 21.9238 | 22.0706 | 13.1884 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0259 | 81.0572 | 83 | Complete curve; high efficacy | -7.5862 | 4.9549 | 0.923 | 16.4972 | 97.5544 | -1.1 | 0 0 0 0 0 0 0 | 2.5125 | 97.0035 | 93.2685 | 8.947 | 36.6707 | 23.4209 | 12.5374 | 2.5125 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.8199 | 85.2901 | 83 | Complete curve; high efficacy | -6.0862 | 1.7529 | 0.994 | 32.3577 | 117.6478 | -1.1 | 0 0 0 0 0 0 0 | 34.7953 | 115.2038 | 115.6711 | 122.13 | 98.3734 | 49.1232 | 31.0106 | 34.7953 | QC'd by Glixx | ||||||||||||||||||||
| Cytotoxic | 0.01 | 90.4383 | 83 | Complete curve; high efficacy | -7.9992 | 1.0641 | 0.9856 | 19.9781 | 110.4164 | -1.1 | 0 0 0 0 0 0 0 | 13.8267 | 101.7041 | 71.2241 | 35.8056 | 28.6279 | 25.0828 | 19.4787 | 13.8267 | QC'd by Analyticon | ||||||||||||||||||||
| Cytotoxic | 0.0092 | 105.8361 | 83 | Complete curve; high efficacy | -8.0362 | 4.095 | 0.9984 | 16.204 | 122.0401 | -1.1 | 0 0 0 0 0 0 0 | 13.8473 | 120.9689 | 28.8486 | 18.131 | 17.3683 | 17.3537 | 14.6878 | 13.8473 | QC'd by SIGMA | ||||||||||||||||||||
| Cytotoxic | 0.4683 | 84.0955 | 83 | Complete curve; high efficacy | -6.3295 | 4.4495 | 0.969 | 29.5128 | 113.6083 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 21.2667 | 108.9911 | 100.6389 | 111.6185 | 114.5273 | 123.8697 | 121.8467 | 50.4844 | 36.163 | 35.4913 | 26.9501 | 21.2667 | QC'd by MedChem Express | ||||||||||||||||
| Cytotoxic | 0.1048 | 82.7642 | 82 | Complete curve; high efficacy | -6.9795 | 1.4163 | 0.9838 | 12.6322 | 95.3964 | -1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 10.5755 | 88.3117 | 93.0926 | 98.2096 | 96.7434 | 61.0096 | 38.8636 | 20.851 | 15.783 | 15.7035 | 9.9048 | 10.5755 | QC'd by BIOMOL | ||||||||||||||||
| Cytotoxic | 0.1778 | 91.155 | 82 | Complete curve; high efficacy | -6.75 | 0.6 | 0.9671 | 13.9433 | 105.0983 | -1.1 | 0 0 0 0 0 0 0 | 9.949 | 96.7816 | 88.0056 | 52.4837 | 44.6307 | 29.7677 | 23.4253 | 9.949 | QC'd by Waterstone | ||||||||||||||||||||
| Cytotoxic | 0.0106 | 101.8256 | 82 | Complete curve; high efficacy | -7.975 | 2.7202 | 0.9927 | 11.1635 | 112.9891 | -1.1 | 0 0 0 0 0 0 0 0 | 10.2995 | 105.5432 | 116.5795 | 42.3861 | 10.2101 | 10.8286 | 11.4633 | 11.6468 | 10.2995 | QC'd by Prestwick | |||||||||||||||||||
| Cytotoxic | 0.6684 | 97.5838 | 82 | Complete curve; high efficacy | -6.175 | 2.3332 | 0.9902 | 18.8259 | 116.4097 | -1.1 | 0 0 0 0 0 0 0 0 | 15.8771 | 121.1891 | 108.6953 | 122.087 | 113.8515 | 96.8463 | 25.1626 | 23.9853 | 15.8771 | QC'd by Enzo | |||||||||||||||||||
| Cytotoxic | 0.0422 | 99.1812 | 82 | Complete curve; high efficacy | -7.375 | 1.3443 | 0.9933 | 10.554 | 109.7352 | -1.1 | 0 0 0 0 0 0 0 0 | 10.7613 | 114.3989 | 100.7838 | 90.7065 | 44.4742 | 11.2028 | 13.8457 | 11.3616 | 10.7613 | QC'd by Tocris | |||||||||||||||||||
| Cytotoxic | 0.0075 | 84.1066 | 82 | Complete curve; high efficacy | -8.125 | 4.9549 | 0.9983 | 9.4344 | 93.541 | -1.1 | 0 0 0 0 0 0 0 0 | 6.5354 | 91.7985 | 94.1104 | 12.6655 | 11.0929 | 8.6327 | 9.9971 | 10.0754 | 6.5354 | QC'd by Bosche | |||||||||||||||||||
| Cytotoxic | 0.4217 | 85.9203 | 82 | Complete curve; high efficacy | -6.375 | 0.8 | 0.9622 | 21.4982 | 107.4185 | -1.1 | 0 0 0 0 0 0 0 0 | 16.639 | 100.4185 | 107.3168 | 112.8293 | 84.5993 | 67.8817 | 38.3542 | 37.8797 | 16.639 | QC'd by Vitas | |||||||||||||||||||
| Cytotoxic | 0.1458 | 95.7444 | 82 | Complete curve; high efficacy | -6.8362 | 1.5579 | 0.9766 | 14.7016 | 110.446 | -1.1 | 0 0 0 0 0 0 0 | 4.7392 | 104.3625 | 115.3478 | 84.3787 | 31.7905 | 25.5998 | 18.0336 | 4.7392 | QC'd by Microsource | ||||||||||||||||||||
| Cytotoxic | 0.0036 | 107.2473 | 82 | Complete curve; high efficacy | -8.444 | 4.9549 | 0.9989 | 8.6172 | 115.8646 | -1.1 | 0 0 0 0 0 0 0 | 7.4398 | 110.6482 | 9.2236 | 10.0332 | 9.492 | 8.9141 | 6.3221 | 7.4398 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.1636 | 80.2947 | 82 | Complete curve; high efficacy | -6.7862 | 2.0479 | 0.9763 | 17.795 | 98.0898 | -1.1 | 0 0 0 0 0 0 0 | 6.7352 | 100.4625 | 95.5674 | 85.028 | 29.2532 | 27.683 | 20.0892 | 6.7352 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 0.0231 | 97.6406 | 82 | Complete curve; high efficacy | -7.6362 | 4.9549 | 0.9995 | 10.3864 | 108.027 | -1.1 | 0 0 0 0 0 0 0 | 10.177 | 107.941 | 98.6844 | 9.8351 | 11.6961 | 11.6717 | 8.8001 | 10.177 | QC'd by Selleck | ||||||||||||||||||||
| Cytotoxic | 1.5877 | 86.3274 | 82 | Complete curve; high efficacy | -5.7992 | 1.331 | 0.9642 | 23.21 | 109.5374 | -1.1 | 0 0 0 0 0 0 0 | 29.2744 | 118.4556 | 99.7114 | 104.7412 | 100.9923 | 85.0976 | 33.9221 | 29.2744 | QC'd by MedChem Express | ||||||||||||||||||||
| Cytotoxic | 0.0146 | 89.4885 | 82 | Complete curve; high efficacy | -7.8362 | 1.2876 | 0.9952 | 9.3441 | 98.8326 | -1.1 | 0 0 0 0 0 0 0 | 7.0005 | 90.7029 | 51.5567 | 22.536 | 11.8774 | 9.8565 | 8.188 | 7.0005 | QC'd by SynKinase | ||||||||||||||||||||
| Cytotoxic | 0.0065 | 96.8431 | 82 | Complete curve; high efficacy | -8.1862 | 4.095 | 0.9948 | 8.9496 | 105.7927 | -1.1 | 0 0 0 0 0 0 0 | 3.839 | 102.1209 | 12.4453 | 11.4448 | 10.8821 | 9.8966 | 7.7027 | 3.839 | QC'd by Selleck |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 0.31 | Kd | = | 310 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 2.3 | Kd | = | 2300 | nM |
| ABLNHiBiTNoATP_10nM_Rep1-Outcome | ABLNHiBiTNoATP_10nM_Rep1-Phenotype | ABLNHiBiTNoATP_10nM_Rep1-Potency | ABLNHiBiTNoATP_10nM_Rep1-Efficacy | ABLNHiBiTNoATP_10nM_Rep1-Analysis Comment | ABLNHiBiTNoATP_10nM_Rep1-Activity_Score | ABLNHiBiTNoATP_10nM_Rep1-Curve_Description | ABLNHiBiTNoATP_10nM_Rep1-Fit_LogAC50 | ABLNHiBiTNoATP_10nM_Rep1-Fit_HillSlope | ABLNHiBiTNoATP_10nM_Rep1-Fit_R2 | ABLNHiBiTNoATP_10nM_Rep1-Fit_InfiniteActivity | ABLNHiBiTNoATP_10nM_Rep1-Fit_ZeroActivity | ABLNHiBiTNoATP_10nM_Rep1-Fit_CurveClass | ABLNHiBiTNoATP_10nM_Rep1-Excluded_Points | ABLNHiBiTNoATP_10nM_Rep1-Max_Response | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.0000556526 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.0001669578 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.0003254584 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.0005555887 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.0009829345 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.00167 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.00250 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.00498 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.00768 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.015 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.025 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.045 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.066 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.135 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.219 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.404 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 0.575 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 1.211 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 1.899 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 3.639 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 4.976 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 10.91 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 16.43 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 26.29 uM | ABLNHiBiTNoATP_10nM_Rep1-Activity at 32.86 uM | ABLNHiBiTNoATP_10nM_Rep2-Outcome | ABLNHiBiTNoATP_10nM_Rep2-Phenotype | ABLNHiBiTNoATP_10nM_Rep2-Potency | ABLNHiBiTNoATP_10nM_Rep2-Efficacy | ABLNHiBiTNoATP_10nM_Rep2-Analysis Comment | ABLNHiBiTNoATP_10nM_Rep2-Activity_Score | ABLNHiBiTNoATP_10nM_Rep2-Curve_Description | ABLNHiBiTNoATP_10nM_Rep2-Fit_LogAC50 | ABLNHiBiTNoATP_10nM_Rep2-Fit_HillSlope | ABLNHiBiTNoATP_10nM_Rep2-Fit_R2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | Activator | 0.1359 | 124.7358 | 94 | Complete curve; high efficacy | -6.8667 | 0.8 | 0.9961 | 122.1454 | -2.5904 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 120.459 | 2.3315 | -5.0754 | 2.4683 | 7.4351 | 22.7024 | 41.878 | 74.4685 | 87.6243 | 109.5524 | 115.841 | 120.459 | 2 | Activator | 0.1525 | 94.3516 | 92 | Complete curve; high efficacy | -6.8167 | 0.7 | 0.9927 | ||||||||||||||||
| 2 | Activator | 0.3123 | 140.7287 | 92 | Complete curve; high efficacy | -6.5054 | 0.5 | 0.998 | 123.904 | -16.8246 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 111.0251 | -9.0069 | -12.3539 | -0.2873 | 9.0008 | 24.3029 | 39.0171 | 58.4048 | 75.0131 | 93.2537 | 102.911 | 111.0251 | 2 | Activator | 0.6231 | 98.5082 | 88 | Complete curve; high efficacy | -6.2054 | 0.5 | 0.9959 | ||||||||||||||||
| 2 | Activator | 0.3932 | 132.1657 | 92 | Complete curve; high efficacy | -6.4054 | 0.6 | 0.994 | 122.6725 | -9.4932 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 111.7235 | -10.411 | -3.695 | -0.0473 | 10.8935 | 17.0199 | 37.0328 | 51.5531 | 81.6286 | 101.8733 | 104.3937 | 111.7235 | 2 | Activator | 0.3932 | 90.4551 | 89 | Complete curve; high efficacy | -6.4054 | 0.8 | 0.9973 | ||||||||||||||||
| 2 | Activator | 0.3123 | 124.1575 | 90 | Complete curve; high efficacy | -6.5054 | 0.7 | 0.9961 | 104.6537 | -19.5038 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 99.6011 | -14.4397 | -20.0031 | -13.3761 | -2.3021 | 0.5124 | 28.5113 | 47.3234 | 69.2577 | 87.0136 | 95.0753 | 99.6011 | 2 | Activator | 0.3123 | 100.1633 | 91 | Complete curve; high efficacy | -6.5054 | 0.7 | 0.9971 | ||||||||||||||||
| 2 | Activator | 0.1756 | 124.8074 | 94 | Complete curve; high efficacy | -6.7554 | 0.7 | 0.9931 | 120.5427 | -4.2647 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 116.805 | -3.9706 | 1.4284 | 4.7057 | 17.1987 | 31.0768 | 51.1933 | 71.4823 | 101.4896 | 113.3934 | 107.1966 | 116.805 | 2 | Activator | 0.3932 | 121.718 | 92 | Complete curve; high efficacy | -6.4054 | 0.7 | 0.99 | ||||||||||||||||
| 2 | Activator | 0.014 | 104.0304 | 97 | Complete curve; high efficacy | -7.8554 | 0.8 | 0.9986 | 100.0304 | -4 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 99.9029 | 1.0033 | 11.3175 | 29.5781 | 50.6936 | 71.1467 | 85.0894 | 92.5319 | 95.1452 | 99.1445 | 101.657 | 99.9029 | 2 | Activator | 0.0111 | 89.2302 | 95 | Complete curve; high efficacy | -7.9554 | 0.6 | 0.9907 | ||||||||||||||||
| 2 | Activator | 0.6992 | 131.069 | 90 | Complete curve; high efficacy | -6.1554 | 0.6 | 0.9979 | 120.2123 | -10.8567 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 108.8879 | -11.964 | -6.1925 | -3.1936 | 4.371 | 9.3955 | 21.3027 | 43.6024 | 66.7659 | 85.5033 | 97.1519 | 108.8879 | 2 | Activator | 0.6992 | 85.7502 | 88 | Complete curve; high efficacy | -6.1554 | 0.8 | 0.9975 | ||||||||||||||||
| 2 | Activator | 0.8802 | 141.0503 | 91 | Complete curve; high efficacy | -6.0554 | 1.3723 | 0.9828 | 142.2981 | 1.2478 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 128.1923 | 4.4446 | -8.1268 | -1.9144 | 9.5614 | 3.9993 | 9.9363 | 41.2117 | 84.0147 | 121.8085 | 154.0023 | 128.1923 | 2 | Activator | 0.6992 | 83.2137 | 87 | Complete curve; high efficacy | -6.1554 | 1.7137 | 0.9508 | ||||||||||||||||
| 2 | Activator | 1.1081 | 131.0379 | 89 | Complete curve; high efficacy | -5.9554 | 0.7 | 0.9963 | 117.6895 | -13.3484 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 106.0266 | -18.207 | -12.9905 | -7.9603 | -1.3557 | -0.9905 | 11.0679 | 28.5061 | 54.1234 | 77.0658 | 97.2072 | 106.0266 | 2 | Activator | 2.211 | 145.0519 | 49 | Partial curve; high efficacy | -5.6554 | 0.6 | 0.9976 | ||||||||||||||||
| 2 | Activator | 0.0028 | 99.189 | 100 | Complete curve; high efficacy | -8.5554 | 1.1 | 0.992 | 99.689 | 0.5 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 103.3864 | 15.2807 | 34.4439 | 68.6896 | 86.0697 | 92.484 | 94.9934 | 99.4661 | 103.8427 | 97.0987 | 99.0617 | 103.3864 | 3 | Activator | 0.0028 | 35.2305 | 29 | Complete curve; partial efficacy | -8.5554 | 1.1 | 0.9892 | ||||||||||||||||
| 2 | Activator | 0.2783 | 100.5358 | 89 | Complete curve; high efficacy | -6.5554 | 1.2221 | 0.9986 | 88.332 | -12.2038 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 89.2242 | -9.3455 | -14.7531 | -11.6635 | -11.6657 | -0.6418 | 17.3174 | 49.5388 | 73.4393 | 82.6045 | 87.071 | 89.2242 | 2 | Activator | 0.1971 | 82.7341 | 91 | Complete curve; high efficacy | -6.7054 | 1.1 | 0.9927 | ||||||||||||||||
| 2 | Activator | 0.0312 | 104.8543 | 94 | Complete curve; high efficacy | -7.5054 | 0.6 | 0.9914 | 90.3511 | -14.5032 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 87.447 | -10.836 | 6.2546 | 11.5035 | 27.5571 | 43.6593 | 61.7396 | 68.7076 | 75.7286 | 85.9984 | 92.3835 | 87.447 | 2 | Activator | 0.0248 | 80.3824 | 93 | Complete curve; high efficacy | -7.6054 | 0.7 | 0.9958 | ||||||||||||||||
| 2 | Activator | 0.0784 | 108.0848 | 92 | Complete curve; high efficacy | -7.1054 | 0.8 | 0.9965 | 95.2355 | -12.8493 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 93.9331 | -12.7911 | -5.8485 | -3.2277 | 12.5717 | 26.7507 | 52.8547 | 76.1577 | 80.4935 | 88.2346 | 95.618 | 93.9331 | 2 | Activator | 0.0495 | 94.2397 | 94 | Complete curve; high efficacy | -7.3054 | 0.7 | 0.9928 | ||||||||||||||||
| 2 | Activator | 0.0035 | 101.7199 | 100 | Complete curve; high efficacy | -8.4554 | 1.5579 | 0.9981 | 100.7199 | -1 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 98.4249 | 5.2665 | 22.9076 | 62.3191 | 91.2131 | 97.4966 | 100.5836 | 101.8145 | 102.6328 | 102.9856 | 99.0103 | 98.4249 | 3 | Activator | 0.0049 | 65.5803 | 32 | Complete curve; partial efficacy | -8.3054 | 1.5579 | 0.9923 | ||||||||||||||||
| 2 | Activator | 0.2211 | 99.7839 | 91 | Complete curve; high efficacy | -6.6554 | 0.8 | 0.9935 | 97.5818 | -2.2021 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 86.5087 | 1.1737 | -3.5017 | 0.5352 | -2.611 | -3.0628 | 11.413 | 20.1238 | 36.5544 | 55.6874 | 77.1973 | 86.5087 | 2 | Activator | 0.1565 | 76.9729 | 90 | Complete curve; high efficacy | -6.8054 | 1 | 0.9868 | ||||||||||||||||
| 2 | Activator | 0.7845 | 130.2083 | 90 | Complete curve; high efficacy | -6.1054 | 0.6 | 0.9957 | 126.3625 | -3.8459 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 111.4307 | -6.9549 | 1.0919 | 7.4844 | 8.6048 | 14.1127 | 28.5346 | 47.198 | 68.9353 | 91.9745 | 106.7179 | 111.4307 | 3 | Activator | 0.2783 | 24.3324 | 10 | Complete curve; partial efficacy; poor fit | -6.5554 | 0.9 | 0.9952 | ||||||||||||||||
| 2 | Activator | 0.2211 | 109.0922 | 92 | Complete curve; high efficacy | -6.6554 | 0.7 | 0.9933 | 109.0922 | 0 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 109.5303 | 0.167 | 1.9361 | 9.4743 | 17.8239 | 25.4955 | 42.412 | 70.0894 | 83.4054 | 97.324 | 95.1672 | 109.5303 | 3 | Activator | 0.2783 | 51.6675 | 25 | Complete curve; partial efficacy | -6.5554 | 0.7 | 0.9989 | ||||||||||||||||
| 2 | Activator | 0.2783 | 105.6913 | 91 | Complete curve; high efficacy | -6.5554 | 0.8 | 0.988 | 106.3255 | 0.6341 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 94.7642 | -1.5549 | -1.3657 | 2.9519 | 5.7296 | 5.1606 | 5.0654 | 23.8643 | 40.2488 | 51.5297 | 82.2085 | 94.7642 | 2 | Activator | 0.5554 | 92.6596 | 49 | Partial curve; high efficacy | -6.2554 | 0.7 | 0.9907 | ||||||||||||||||
| 2 | Activator | 0.1756 | 104.1596 | 91 | Complete curve; high efficacy | -6.7554 | 0.6 | 0.9931 | 99.3037 | -4.8558 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 97.3566 | 2.5958 | -1.1299 | 4.4256 | 12.0096 | 26.8741 | 47.7237 | 59.5187 | 72.587 | 79.2471 | 93.3388 | 97.3566 | 3 | Activator | 0.3504 | 67.8469 | 26 | Complete curve; partial efficacy | -6.4554 | 0.5 | 0.9957 | ||||||||||||||||
| 2 | Activator | 0.0441 | 119.9345 | 97 | Complete curve; high efficacy | -7.3554 | 0.9 | 0.9948 | 115.7496 | -4.1849 | 1.1 | 0 0 0 0 0 0 0 0 0 0 0 | 108.3982 | -3.4874 | 1.5746 | 12.2936 | 28.4694 | 60.0726 | 82.6061 | 100.5577 | 108.934 | 114.6933 | 122.0987 | 108.3982 | 3 | Activator | 0.0197 | 36.9521 | 27 | Complete curve; partial efficacy | -7.7054 | 1 | 0.982 |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 1.6 | Kd | = | 1600 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 4.2 | Kd | = | 4200 | nM |
| PubChem Standard Value | Standard Type | Standard Relation | Standard Value | Standard Units |
|---|---|---|---|---|
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |
| 5 | Kd | = | 5000 | nM |
| 10 | Kd | > | 10000 | nM |
| 10 | Kd | > | 10000 | nM |